IBH Publications

Adams RS, Corrigan JD, Ritter GA, Pringle ZA, Zolotusky G, Blayney R, Reif S. (2024) Association of disability status with alcohol use with prescription opioid use behaviors among adults from a 3-state sample in 2018. Substance Use and Addiction Journal, 45(3):453-465.   

Adams RS, Forster JE, Gradus JL, Hoffmire CA, Hostetter TA, Larson MJ, Smith AA, Walsh CG, Brenner LA. (2024) Divergent trends in accidental deaths since return from an Afghanistan/Iraq deployment among Army soldiers. Annals of Epidemiology, 91:23-29. PMCID: PMC10973698

Adams RS, Huntington N, Highland KB, Moresco N, Carpenter J, Buchholz C, Larson MJ, (2024) Trends in annual prescription opioid receipt among US military members in the Military Health System during 2016-2021, by service, component, and deployment history. Regional Anesthesia & Pain Medicine, 19:rapm-2023-105170.   PMCID: PMC11331023  

Adams RS, McKetta SC, Jager J,  Stewart MT, Keyes KM. (2024) Cohort effects of women's mid-life binge drinking and alcohol use disorder symptoms in the United States: Impacts of changes in timing of parenthood. Addiction, 118(10):1932-1941. PMCID: PMC10527386

 Allchin B, Albermann K,  Blake-Holmes K, Gatsou L, Hine R, van Doesum, K, Nicholson J. (2024) Sustaining efforts to improve family well-being with parents with mental ill health and substance (mis)use.  Front Psychiatry, 25:15:1376409. PMCID: PMC1003303

Bhardwaj A, Sousac JL,  Huskamp HA, Busch AB, Kennedy-Hendricks A, Hodgkin D, Horgan C, Uscher-Pines L. (2024) Prescribing Medications for Alcohol Use Disorder: A Qualitative Study of Primary Care Physician Decision Making. Ann Fam Med, 21 (4) 332-337.   PMCID: PMC10365869

Blough MJ, Rocha A, Bratberg J, Silcox J, Bolivar D, Floyd A S, Gray M, Green TC. (2024) The Cost of Safe Injection: Insights on Nonprescription Syringe Price Variability From Systematic Secret Shopping. Substance Use & Addiction Journal, 45(2):201-210.

Bowser D, Bohler R, Davis MT, Hodgkin D, Horgan CM (2024). Payment-Related Barriers to Medications for Opioid Use Disorder: A Critical Review of the Literature and Real-World Application. Journal of Substance Use and Addiction Treatment, 165: 209441.

Brolin, M., Kim, M., et al. (2024). Medications for Opioid Use Disorder (MOUD) Initiatives under SAMHSA’s Substance Use Prevention Treatment, and Recovery Services Block Grant (SUPTRS-BG), State Opioid Response (SOR), and Medication Assisted Treatment-Prescription Drug and Opioid Addiction (MAT-PDOA) Grant Programs. Base Year Evaluation, Data Analysis Report. SAMHSA Reference No. 283-22-4601.

Davis MT, Tschampl C, Hodgkin D, Regis C, Taveras E, Plant B, Reilly B, Horgan C (2024). Mobile Clinics for Opioid Use Disorders: What They Do and How They Do It. A Qualitative Analysis. Journal of Substance Use and Addiction Treatment, 164: 209428. 

Floyd AS, Silcox J, Strickler G, Nong T, Blough M, Bolivar D, Rabin M, Bratberg J, Irwin AN, Hartung DM, Hansen RN, Bohler R, Green TC. (2024)  Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informant interviews. Drug and Alcohol Dependence Reports, 11:100243.  PMCID: PMC11214408 

Friedmann PD, Jawa R, Wilson D, Ramsey SE, Hoskinson, Jr R, McKenzie M, Walley AY, Green TC, Bratberg J, Rich JD. (2024) Prescribe to Save Lives: An Intervention to Increase Naloxone Prescribing Among HIV Clinicians. J Addict Med, 17(5):598-603. PMCID: PMC10593983

Green TC, Silcox J, Bolivar D, Gray M, Floyd A, Irwin AN, Hansen RN, Hartung DM, Bratberg JB. (2024) Pharmacy staff-reported adaptations to naloxone provision and over the counter (OTC) syringe sales during the COVID-19 pandemic: experiences across multiple states and two pharmacy chains. Journal of the American Pharmacists Association, 64(1):71-78  PMCID: PMC11014459

Harvey LH, Green TC, Park JN, Rich JD. (2024) U.S. policy responses to xylazine: Thinking bigger. International Journal of Drug Policy, 130:104517. 

Heyman M, Nicholson J, English K. (2024). The ParentingWell Practice Approach: Facilitating adaptation and sustainment in U.S. adult mental health services. Frontiers in Psychiatry, 15:1377088. PMCID: PMC11247391

Hodgkin D, Busch AB, Kennedy-Hendricks A, Azeni H, Horgan CM, Uscher-Pines L, Huskamp HA (2024). Unfilled Prescriptions and the Utilization of Medications for Alcohol Use Disorder. Journal of General Internal Medicine, in press.

Irwin AN, Gray M, Ventricelli D, Boggis JS, Bratberg J, Floyd AS, Silcox J, Hartung DM, Green TC. “I go out of my way to give them an extra smile now:” A Study of Pharmacists Who Participated in Respond to Prevent, a Community Pharmacy Intervention to Accelerate Provision of Harm Reduction Materials. Research in Social and Administrative Pharmacy. (2024); 20(5):512-519.

Jack HE, Arif SA, Moore MA, Bhatraju EP, Thompson JL, Stewart MT, Hawk K, Bartlett E. (2024) Peer support for patients with opioid use disorder in the emergency department: A narrative review. Journal of the American College of Emergency Physicians, 5(4):e13253. PMCID: PMC11322658 

Okrant E, Reif S, Horgan CM. (2024) Development of an addiction recovery patient-reported outcome measure: Response to Addiction Recovery (R2AR). Subst Abuse Treat Prev Policy, 18(1):52.  PMCID: PMC10474628

Park JN, Tardif J, Thompson E, Rosen JG, Arredondo J, Lira S, Green TC. (2024) A survey of North American drug checking services operating in 2022. Int J Drug Policy, 121:104206.  PMCID: PMC10843152

Park JN, Serafinski R, Ujeneza M, McKenzie M, Tardif J, Krotulski AJ, Badea A, Grossman ER, Green TC. (2024) Xylazine Awareness, Desire, Use and Exposure: Preliminary Findings from the Rhode Island Community-Based Drug Checking Cohort Study. Drug and Alcohol Dependence Reports, 11:100247. PMCID: PMC11225690

Pham HH, Benevides TW, Andresen ML, Bahr M, Nicholson J, Corey T, Jaremski JE, Faughnan K, et al. (2024) Advancing health policy and outcomes for people with intellectual or developmental disabilities: A community-led agenda. JAMA Health Forum, 5(8):e242201.

Rapisarda SS, Silcox J, Case P, Palacios WR, Stopka T J, Zaragoza S, Hughto JMW, Shrestha S, Green TC. (2024). Rapid Assessment Amid an Injection Drug Use-Driven HIV Outbreak in Massachusetts’ Merrimack Valley: Highlights from a Case Study. AIDS and Behavior.  

Reed MK, Esteves Camacho T, Olson R, Grover Z, Rapoza T, Larson, M. J. (2024). Xylazine’s Impacts on the Community in Philadelphia: Perspectives of People Who Use Opioids and Harm Reduction Workers. Substance Use & Misuse, 1-8.

Schoenberger SF, Cummins ER, Carroll JJ, Yan S, Lambert A, Bagley SM, Xuan Z, Green TC, Cook F, Yule AAM, Walley AY, Formica SW. (2024) Wanna cry this out real quick?: An examination of secondary traumatic stress risk and resilience among post-overdose outreach staff in Massachusetts. Harm Reduction Journal, 21(1):66.  PMCID: PMC10949647

Shrestha S, Stopka TJ, Hughto JMW, Case P, Palacios WR, Reilly B, Green TC. (2024) LatinX harm reduction capital, medication for opioid use disorder, and nonfatal overdose: A structural equation model analysis among people who use drugs in Massachusetts. Drug and Alcohol Dependence, 259:111293.

Silcox JW, Stewart E. (2024). The Professionalization of Stigma: The Novel Case of Recovery Coaching. Journal of Applied Social Science, 18(1), 204-221. 

Silcox J, Rapisarda SS, Hughto JMW, Vento S, Case P, Palacios WR, Zaragoza S, Shrestha S, Stopka TJ, Green TC. (2024) Views and experiences of involuntary civil commitment of people who use drugs in Massachusetts (Section 35). Drug Alcohol Depend, 263:112391.

Stewart M, Daily SM, Thomas CP, Panas L, Ritter G, Reif S, Thomas CP, Panas L, Ritter G, Reif S. (2024) Expanding access to medication treatment for opioid use disorders: Findings from the Washington State hub and spoke effort.  Drug Alcohol Depend, 256:111125.  PMCID: PMC10922849 

Thompson E, Tardif J, Ujeneza M, Badea A, Green TC, McKee H, McKenzie M, Park JN. (2024) Pilot findings on the real-world performance of xylazine test strips for drug residue testing and the importance of secondary testing methods. Drug Alcohol Depend Rep, 11:100241. PMCID: PMC11131062.

Woodruff J, Bratberg J, Feltus SR, Gray HV, Green T, Kelsey S, Stewart MT, Tschampl CA, Weinstein SP. Pharmacy-(2024) based methadone: Analysis of current laws and regulations. Waltham, MA: Brandeis University.

Zang X, Skinner A, Krieger MS, Behrends CN, Park JN, Green TC, Walley AY, Morgan JR, Linas BP, Yedinak JL, Schackman BR, Marshall BDL. (2024) Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid Settlement. JAMA Network Open, 7(5):e2413861.  PMCID: PMC11140538.

Bauer MR, Richard P, Ritter G, Yoon J, Larson MJ. (2023) Clinician approaches to new spine pain cases in primary care: Balance of opioid prescribing and early linkage to exercise therapy and spinal manipulation. Journal of Evaluation in Clinical Practice. J Eval Clin Pract, 30(3):355-366.  PMCID: PMC11023770

Benrubi LM, Silcox J, Hughto J, Stopka TJ, Palacios WR, Shrestha S, Case P, Green TC. (2023) Trends and Correlates of Abscess History Among People Who Inject Drugs in Massachusetts: A Mixed Methods Exploration of Experiences Amidst a Rapidly Evolving Drug Supply. Drug and Alcohol Dependence Reports, 8:1000176.  PMCID: PMC10518505 

Bhardwaj A, Sousa JL, Huskamp HA, Busch AB, Kennedy-Hendricks A, Hodgkin D, Horgan C, Uscher-Pines L (2023). Prescribing Medications for Alcohol Use Disorder: A Qualitative Study of Primary Care Physician Decision-Making. Annals of Family Medicine, 21(4): 332-337.  PMCID: PMC10365869

Bohler RM, Freeman PR, Villani J, Hunt T, Linas BS, Walley AY, Green TC, Lofwall MR, Bridden C, Frazier LA, Fanucchi LC, Talbert JC, Chandler R. (2023) The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses. Drug Alcohol Depend Rep, 6:100126.  PMCID: PMC9838196.

Bolivar D, Hartung D, Silcox J, Bratberg J, Boggis J, Rabin M, Green TC. (2023) Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire. J Am Pharm Assoc, 63(1):330-335. PMCID: PMC9574786

Bowser D, Bohler R, Davis MT, Hodgkin D, Frank RG, Horgan CM. (2023) New Methadone Treatment Regulations Should Be Complemented By Payment And Financing Reform. Health Affairs Forefront. Published online June 1, 2023. 10.1377/forefront.20230531.974690

Brenner LA, Forster JE, Gradus JL, Hostetter T, Hoffmire CA, Walsh CG, Larson MJ, Stearns-Yoder K, Adams RS. (2023) Military-related Traumatic Brain Injury Increases Rates of New Onset Mental Health Conditions and Risk for Suicide. JAMA Network Open, 6(7):e2326296.  PMCID: PMC10391302

Brenner LA, Forster JE, Walsh CG, Stearns-Yoder KA, Larson MJ, Hostetter TA,Hoffmire CA, Gradus JL, Adams RS, (2023) Trends in suicide rates by race and ethnicity among members of the United States Army. PLOS One,18(1):e0280217. PMCID: PMC9844903

Carroll JJ, Cummins ER, Formica SW, Green TC, Bagley SM, Beletsky L, Rosenbloom D, Xuan Z, Walley AY. (2023) The police paradox: A qualitative study of post-overdose outreach program implementation through public health-public safety partnerships in Massachusetts. International Journal of Drug Policy, 120:104160. 

Cepeda JA, Thompson E, Ujeneza M, Tardif J, Walsh T, Morales A, Rosen JG, Green TC, Park JN. (2023) Costing analysis of a point-of-care drug checking program in Rhode Island. Drug Alcohol Depend, 253:111028.  PMCID: PMC11238094

Crowe-Cumella H, Nicholson J, Aguilera A, McCall T, Fortuna KL. (2023) Editorial: Digital health equity. Front Digit Health,5:1184847. PMCID: PMC10186619.

Davidson G, Allchin B, Kate Blake-Holmes K, Grant A, Lagdon S, McCartan C, Maybery D, Nicholson J, Reupert A. (2023) Supporting Service Recipients to Navigate Complex Service Systems: An Interdisciplinary Scoping Review. Health & Social Care in the Community, 2:8250781.

Davis MT, Bohler R, Hodgkin D, Hamilton G, Horgan C. (2023) The role of health plans in addressing the opioid crisis: A qualitative study. J Subst Use Addict Treat,149:209022. PMCID: PMC10198902

Floyd AS, Silcox J, Cousin E, Irwin AN, Gray M, Bolivar D, Bratberg J, Arnold J, Al-Jammali Z, Hansen RN, Hartung DM, Green TC. (2023) Readiness of community pharmacies to implement an opioid safety intervention. J Am Pharm Assoc (2003), 63(1):275-283.e1. PMCID: PMC9870924

Fortuna KL, Lebby S, Geiger P, Johnson D, MacDonald S, Chefetz I, Ferron JC, St George L, Rossom R, Kalisa J, Mestrovic T, Nicholson J, Pringle W, Rotondi AJ, Sipped LM, Sica A, Solesio ME, Wright M, Zisman-Ilani Y, Gambee D, Hill J, Brundrett A, Cather C, Rhee TG, Daumit GL, Angel J, Manion I, Deegan PE, Butler JA, Pitts N, Brodey DE, Williams AM, Parks J, Reimann B, Wahrenberger JT, Morgan O, Bradford DW, Bright N, Stafford E, Bohm AR, Carney T, Haragirimana C, Gold A, Storm. (2023) Lived Experience-Led Research Agenda to Address Early Death in People With a Diagnosis of a Serious Mental Illness: A Consensus Statement. JAMA Netw Open, 6(5):e2315479.

Fortuna, KL, Kadakia, A, Costco, T, Rotondi, A, Nicholson, J, Walker, R, Hamilton, J, Brewer, L, Collins-Pisano, C, Barr, P, Hudson, M, Joseph, J, Mullaly, C, Booth, M, & Lebby, S. (2023). Guidelines to Establish an Equitable Mobile Health Ecosystem. Psychiatric Services, 74(4): 393-400.  PMCID: PMC11398716

Friedmann PD, Jawa R, Wilson D, Ramsey SE, Hoskinson R Jr, McKenzie M, Walley AY, Green TC, Bratberg J, Rich JD. (2023) Prescribe to Save Lives: An Intervention to Increase Naloxone Prescribing Among HIV Clinicians. J Addict Med, 17(5):598-603. PMCID: PMC10593983

Gray M, Shin SS, Silcox J, Flores D, Bolivar D, Irwin AN, Floyd AS, Bratberg J, Boggis JS, Hartung DM, Green TC. (2023) Like it Was Just Everyday Business: A Qualitative study of Pharmacy-Based Naloxone and Syringe Customer Experience. Journal of American Pharmacists Association, 17(5):598-603. PMCID: PMC10593983  

Green TC, Serafinski R, Clark SA, Rich JD, Bratberg J. (2023) Physician-Delegated Unobserved Induction with Buprenorphine in Pharmacies. N Engl J Med, 388(2):185-186. PMCID: PMC10075193 

Green TC. (2023) Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: Findings from a mixed-methods study of people who use drugs. Subst Abuse Treat Prev Policy, 18(1):30. PMCID: PMC10201806.

Hendricks, MA, El Ibrahimi S, Ritter GA, Flores D, Fischer MA, Weiss RD, Wright DA, Weiner SG. (2023) Association of Household Opioid Availability With Opioid Overdose. JAMA Network Open, 6(3): e233385. PMCID: PMC10024199.

Hill LG, Light AE, Green TC, Burns AL, Sanaty Zadeh P, Freeman PR. (2003) Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists. J Am Pharm Assoc, 63(1):252-260.e6.  PMCID: PMC9870924  

Hodgkin D, Horgan CM, Brown SJ, Bart G, Stewart MT (2023). Financial sustainability of novel delivery models in behavioral health treatment. Journal of Mental Health Policy and Economics, 26(4):149-158.

Hughto JMW, Tapper A, Rapisarda S, Stopka TJ, Palacios W, Case P, Silcox J, Moyo P, Green TC. (2023) Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs. Subst Abuse Treat Prev Policy, 18:30. PMCID: PMC10201806. 

Irwin AN, Bratberg JP, Al-Jammali Z, Arnold J, Gray M, Floyd AS, Bolivar D, Hansen R, Hartung DM, Green TC. (2023) Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician. J Am Pharm Assoc, 63(1):284-294.e1. PMCID: PMC9933140.

Kachoria AG, Sefton L, Miller F, Leary A, Goff SL, Nicholson J, Himmelstein J, Alcusky M. (2023) Facilitators and Barriers to Care Coordination Between Medicaid Accountable Care Organizations and Community Partners: Early Lessons from Massachusetts. Med Care Res Rev, 10775587231168010. 

Kim LH, Hodgkin D, Larson MJ, Doonan M (2023).  Changes in Racial and Ethnic Disparities in use of mental health services under the Affordable Care Act: Evidence from California. Journal of Mental Health Policy and Economics, 26(1):19-32.   

Kim ML, Dalvi N, Valerio DD, Strickler GK, Young L D. (2023). Prescribed stimulant medications: Trends in the last decade, pre and post COVID-19 response. Exploratory Research in Clinical and Social Pharmacy, 11:100314. PMCID: PMC10470379

Kritikos A, Pacula RL, Johnson J, Hodgkin D (2023).  Simultaneous Cannabis and Alcohol Use Among Medical Cannabis Patients. Substance Use & Misuse, 59L6):847-857.

Larson, Mary Jo, Ritter, Grant, Adams, Rachel Sayko (2023). Opioid Prescribing to US Military Members. Regional Anesthesia & Pain Medicine, rapm-2023-105067.  PMCID: PMC11058102  

McCall T, Nicholson J, Aguilera A, Fortuna K. (2023). Digital Health Equity. Front Digit Health, 5:1184847.   

Nghiem, Vi. T., Larson, Mary Jo, Adams, Rachel Sayko, Moresco, Natalie, and Highland, Krista, B. (2023). Opioid Prescription Clusters Associated with Early or Unplanned Military Separation. Military Medicine, 189(3-4):e748-e757.   PMCID: PMC10898939

Nicholson J, Mazel S, Faughnan K, Silverman A. (2023) Mothers with Intellectual/Developmental Disabilities and Behavioral Health Conditions and Community Experts Provide Recommendations for Treatment/Services, Systems, and Research. Int. J Environ. Res. Public Health, 20(10):5876. PMCID: PMC10218658.

Okrant E, Reif S, Horgan, CM. (2023) Development of an addiction recovery patient-reported outcome measure: Response to Addiction Recovery (R2AR).  Substance Abuse Treatment. Prevention, and Policy, 18:52. PMCID: PMC10474628

Park JN, Tardif J, Thompson E, Rosen JG, Lira JAS, Green TC. (2023) A survey of North American drug checking services operating in 2022. Int J Drug Policy,  121:104206. PMCID: PMC10843152.

Park JN, Green TC, Rich JD. (2023) Overdose Detection Technologies—A New Frontier in Preventing Solitary Drug Overdose Deaths. JAMA Psychiatry, 80(7):657-659. 

Pogue YZ, Lavelle TA, Hodgkin D, Sylvia L, Ritter G, Nierenberg A (2023). Psychometric Performance of the SF-6D Quality of Life Measure in an Outpatient Population with Bipolar Disorder.  Journal of Mental Health Policy and Economics, 25(4):143-150.

Reif S, Lee MT, Ledingham E. (2023) The Intersection of Disability With Substance Use and Addiction. Book Chapter.  Oxford Research Encyclopedia of Global Public Health, Oxford University Press.

Silcox J, Rapisarda S, Hughto J, Vento S, Case P, Palacios WR, Zaragoza S, Shrestha S, Green T. C. (2023). Views and Experiences of Involuntary Civil Commitment of People Who Use Drugs in Massachusetts (Section 35).  Drug Alcohol Depend, 263:112391

Silcox J, Rapisarda S, Hughto J, Vento S, Case P, Palacios WR, Zaragoza S, Shrestha S, Green T. C. (2023). A Qualitative Analysis on the Views and Experiences of Involuntary Civil Commitment of People Who Use Drugs in Massachusetts (Section 35). In SSRN Electronic Journal, Brandeis University.  

Thomas CP, Stewart MT, Ledingham E, Adams RS, Panas L, Reif S. (2023) Quality of Opioid Use Disorder Treatment for Persons With and Without Disabling Conditions. JAMA Netw Open, 1;6(3):e232052.  PMCID: PMC9996401  

Tschampl CA, Regis C, Johnson NE, Davis MT, Hodgkin D, Brolin MF, Do E, Horgan CM, Green TC, Reilly B, Duska M, Taveras EM. (2023) Protocol for the implementation of a statewide mobile addiction program. J Comp Eff Res, 12(5):e220117. PMCID: PMC1040748 

Xuan Z, Yan S, Formica SW, Green TC, Beletsky L, Rosenbloom D, Bagley SM, Kimmel SD, Carroll JJ, Lambert AM, Walley AY. (2023) Association of Implementation of Post-Overdose Outreach Programs with Subsequent Opioid Overdose Deaths among Massachusetts Municipalities. JAMA Psychiatry, 80(5):468–477. PMCID: PMC10018400.

Adams RS, Ledingham E, Keyes KM. (2022) Have we overlooked the influence of “Wine-Mom” culture on alcohol consumption among mothers? Editorial in Addictive Behaviors,124:107119.

Adams RS, Forster JE, Gradus JL, Hofflire CA, Hostetter TA, Larson MJ, Walsh CG, Brenner LA. (2022) Time-dependent suicide rates among Army soldiers returning from an Afghanistan/Iraq deployment, by military rank and component. Inj Epidemiol, 23;9(1):46.  PMCID: PMC9783392

Bauer MR, Larson MJ, Moresco N, Huntington N, Walker R, Richard P. (2022) Association between 1-year patient outcomes and opioid-prescribing group of emergency department clinicians: A cohort study with Army active-duty soldiers. Academic Emergency Medicine, 28(11):1251-1261.

Bolivar D, Hartung D, Silcox J, Boggis J, Bratberg J, Rabin M, Green TC. (2022) Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire. Journal of American Pharmacist Association, online ahead of print. PMCID: PMC9574786

Bolton R, Ritter G, Highland K, Larson MJ. (2022) The Relationship Between Capacity and Utilization of Nonpharmacologic Therapies in the US Military Health System. BMC Health Services Research, 22(1):312. PMCID: PMC8900315.

Brolin M, Reif S, Buell J, Whitcher H, Jaghoo S, McNeil P. (2022) Screening and Brief Intervention With Low-Income Youth in Community-Based Settings. Journal of Adolescent Health, 71(4):S65-S72.

Buell J, Mazel S, Zisman-Ilani Y, Hennig S, Nicholson J. (2022) Toolkit:  For researchers and community experts interested in maternal mental health and/or substance use/recovery, and Tip Sheets: Sharing research findings with mothers. See Supplementary Materials. Frontiers in Psychiatry, 13:805781. PMCID: PMC9240264.

Chatterjee A, Yan S, Xuan Z, Waye KM, Lambert AM, Green TC, Stopka TJ, Pollini RA, Morgan JR., Walley AY. (2022) Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts. Drug and Alcohol Dependence, 230:109190.  PMCID: PMC8714703.

Clark TW. (2022) Causal Responsibility For Addiction. Addictive Behaviors, 130:107292.

Fortuna KL, Kadakia A, Cosco T, Rotondi A, Nicholson J, Walker R, Hamilton J, Brewer L, Collins-Pisano C, Barr P, Hudson M, Joseph J, Mullaly C, Booth M, Lebby S. (2022) Guidelines to Establish an Equitable Mobile Health Ecosystem. Psychiatric Services, obline ahead of  print.

Floyd AS, Silcox J, Cousin E, Irwin AN, Gray M, Bolivar D, Bratberg J, Arnold J, Al-Jammali Z, Hansen RN, Hartung DM, Green TC. (2022) Readiness of community pharmacies to implement an opioid safety intervention. J Am Pharm Assoc, 63(1):275-283.e1. PMCID: PMC9870924.

Green TC, Hartung D, Irwin A, Boggis J, Gray M, Floyd A, Leichtling G, Bolivar D, Bratberg J. (2022) Study Protocol for the Respond to Prevent Study: A multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies. Substance Abuse, 43(1):901-905.

Green TC, Olson R, Jarczyk C,  Erowid E, Erowid F, Thyssen S, Wightman R, del Pozo B, Michelson L, Consigli A, Reilly B, Ruiz S. (2022) Implementation and uptake of the Massachusetts Drug Supply Data Stream: a state-wide public health-public safety partnership drug checking program. Journal of Public Health Management and Practice, 28(Suplement 6):S347-S354. PMCID: PMC9531987.

Hill LG, Light AE, Green TC, Burns AL, Sanaty Zadeh P, Freeman PR. (2022) Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists. J Am Pharm Assoc, 63(1):252-260.e6.

Himmelstein J, Alcusky M, Ash A, Clements K, Gershon R, Mick E, Nicholson J, Wang Y. (2022). Independent Evaluation Interim Report, Massachusetts Medicaid 1115 Demonstration, Extension 2017-2022. Accepted by CMS, September 29, 2022.

Irvine MA, Oller D, Boggis J, Bishop B, Coombs D, Wheeler E, Doe-Simkins M, Walley AY, Marshall BDL, Bratberg J, Green, TC. (2022) Estimating Naloxone Need in the United States Across Fentanyl, Heroin, and Prescription Opioid Epidemics: A Modelling Study. The Lancet Public Health, 7(3):210-218. 

Jawa R, Walley AY, Wilson DJ, Green TC, McKenzie M, Hoskinson R Jr, Bratberg J, Ramsey S, Rich JD, Friedmann PD. (2022) Prescribe to Save Lives: Improving Buprenorphine Prescribing Among HIV Clinicians. J Acquir Immune Defic Syndr, 90(5):546-552. PMCID: PMC9283214.

Kozasa EH,  Nicholson J. (2022). Editorial: Women in Science: Public Mental Health 2021. Frontiers in Public Health, 10:1005116.  PMCID: PMC9461712

Larson MJ, Bauer MR, Moresco N, Huntington N, Ritter G, Paul-Kagiri R, Hyppolite R, Richard P. (2022) Variation in prescribing of opioids for emergency department encounters: A cohort study in the Military Health System. J Eval Clin Pract, online ahead of print.  

Ledingham EC, Adams RS, Heaphy D, dUarte A, Reif S. (2022) Perspectives of adults with disabilities and opioid misuse: Qualitative findings illuminating experiences with stigma and substance use treatment. Disability & Health Journal, 101292.

Meerwijk EL, Adams RS, Larson MJ, Highland KB, Harris AHS. (2022) Dose of Exercise Therapy Among Active Duty Soldiers with Chronic Pain is Associated with Lower Risk of Long-Term Adverse Outcomes After Linking to the Veterans Health Administration. Military Medicine, usac074.

Miles J, Mericle A, Ritter G, Reif S. (2022) Association of facility characteristics and substance use disorder outcomes at discharge from residential treatment. Journal of Substance Abuse Treatment, 136:108664.

Nicholson J, Paul JL, Riebschleger J, & Wittkowski A. (2022). Editorial: Parents with mental and/or substance use disorders and their children, volume II. Frontiers in Psychiatry, Sec. Public Me 13:1020660.  PMCID: PMC9513570   

Nicholson J,  Valentine A, Ledingham E, Reif S. (2022) Peer Support at the Intersection of Disability and Opioid (Mis)Use: Key Stakeholders Provide Essential Considerations. Int J Environ Res Public Health, 19(15):9664. PMCID: PMC9368223 

Nicholson, J, English K, Heyman M. (2022) The ParentingWell Learning Collaborative Feasibility Study: Training Adult Mental Health Service Practitioners in a Family‑Focused Practice Approach. Community Mental Health Journal, 58(2):261-276. PMCID: PMC8019525.

Nicholson J, Heyman M, English K, Biebel K. (2022) The ParentingWell practice approach: Adaptation of Let’s Talk about Children for parents with mental illness in adult mental health services in the USA. Frontiers in Psychiatry, 13: 801065.

Nicholson J, Heyman M, English K, Biebel K. (2022) Talk About Children for Parents With Mental Illness in Adult Mental Health Services in the United States. Frontiers in Psychiatry, 13: 806550.

Obradovic A, Nicholson J. (2022) Perspective: Implications of the COVID-19 Pandemic for Family-Focused Practice With Parents With Mental Illness and Their Families. Frontiers in Psychiatry, 13:806550.

O’Brien ML, Stewart MT, Shields MC, White M, Dubenitz J, Dey J, Mulvaney-Day N. (2022) Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field. Drug and Alcohol Dependence Reports, 4:100087. PMCID: PMC9495301.

Olson R, Case P, Palacios W, Hunter A, Lopes-McCoy V,  Green TC. (2022) Law enforcement and community provision of fentanyl test strips to people who use drugs for engagement and referral to services. Journal of Public Health Management and Practice, 28 (Supplement 6):S343-S346. PMCID: PMC9531966 

Pollini RA, Slocum S, Ozga JE, Joyce R, Xuan Z, Green TC, Walley AY. (2022) Pharmacy naloxone co-dispensing: A mixed methods study of practices and perspectives under a statewide standing order program. J Am Pharm Assoc, S1544-3191(22)000087-5.

Reif S, Brolin M, Beyene TM, D’Agostino N, Stewart MT, Horgan CM. (2022) Payment and Financing for Substance Use Screening and Brief Intervention for Adolescents and Adults in Health, School, and Community Settings. Journal of Adolescent Health, 71(4): S73-S82. PMCID: PMC9945348 

Reif S, Karriker-Jaffe KJ, Valentine A, Patterson D, Mericle AA, Adams RS, Greenfield TK. (2022) Substance use and misuse patterns and disability status in the2020 US National Alcohol Survey: a contributing role for chronic pain. Disability and Health Journal, 101290.

Reif S, Mitra M. (2022) The complexities of substance use disorder and people with disabilities: Current perspectives. Disability & Health Journal, 15(2S):101285. 

Reif S, Brolin M, Beyene TM, D’Agostino N, Stewart MT, Horgan CM. (2022)  Payment and financing for substance use screening and brief intervention for adolescents and adults  in health, school, and community settings. Journal of Adolescent Health, 2022; 71(4):S73-S82. 

Reupert A, Bee P, Hosman C, Doesum K, Drost LM, Falkov A, Foster K, Gatsou L, Gladstone B, Goodyear M, Grant A, Grove C, Isobel S, Kowalenko N, Lauritzen C, Maybery D, Mordock E, Nicholson J, Reedtz C, Solantaus T, Stavnes K, Weirmand BM, Yates S, Ruud T. (2022) Prato Research Collaborative for change in parent and child mental health - Principles and recommendations for working with children and parents living with parental mental illness. The Journal of Child Psychology and Psychiatry, 3(63):350-353.

Silwal A, South AM, Thomas CP, Talbert J, Fanucchi L, Lofwall M, Bohler R. (2O22). New HHS Guidance for Increasing Number of Buprenorphine Clinicians Who Can Treat OUD. The Hospitalist. Published online. 

Thomas CP, Stewart MT,  Tschampl C, Sennaar K, Schwartz D, Dey J. (2022) Emergency Department Interventions for Opioid Use Disorder: A Synthesis of Emerging Models. Journal of Substance Abuse Treatment, 141:108837. 

Tori ME, Cummins E, Beletsky L, Schoenberger SF, Lambert AM, Yan S, Carroll JJ, Formica SW,  Green TC , Apsler R Xuan, Z, Walley AY.  (2022) Warrant checking practices by post-overdose outreach programs in Massachusetts: A mixed-methods study. Int J Drug Policy, 100:103483.  

Tschampl CA, Canuto M, De Jesus D, D'Ippolito M, Guzman M, Larson MJ,  Stewart E, Lundgren L. (2022) Adverse childhood experiences are associated with increased overdose risk in predominately Latinx adults seeking treatment for substance use disorders. Front Psychiatry, 13:987085. PMCID: PMC9798211 

Valentine A, Walker R, Nicholson J. (2022) Key considerations in building organizational capacity to implement peer supports for parents with mental illness. Advance in Mental Health, 26-37.

Weiner SG, Hendricks MA, Ibrahimi SE, Ritter GA, Hallvik SE, Hildebran C, Weiss RD, Boyer EW, Flores DP, Nelson LS, Kreiner PW, Fischer MA. (2022) Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone. National Library of Medicine, 17(4):0266561.  PMCID: PMC8982846.

Weiner SG, Ibrahimi SE, Hendricks MA, Hallvik SE, Hildebran C, Fischer MA, Weiss RD, Boyer EW, Kreiner PW, Wright DA, Flores DP, Ritter GA. (2022) Factors Associated With Opioid Overdose After an Initial Opioid Prescription. JAMA Network Open, 5(1):2145691. PMCID: PMC8800077.

Williams AR, Johnson KA, Thomas CP, Reif S, Socías ME, Henry BF, Neighbors C, Gordon AJ, Horgan C, Noysk B, Drexler K, Krawcyzk N, Gonsalves G, Hadland S, Stein B, Fishman M, Kelley AT, Pincus HA, Olfson M. (2022) Opioid use disorder Cascade of care framework design: A roadmap. Substance Abuse, 43(1):207-1214. PMCID: PMC9577537.

Zisman-Ilani Y, Buell J, Mazel S, Hennig S and Nicholson J (2022) Virtual Community Engagement Studio (V-CES): Engaging Mothers With Mental Health and Substance Use Conditions in Research. Frontiers in Psychiatry. 13:805781.  PMCID: PMC9240264  

Adams RS, Meerwijk EL, Larson MJ, Harris HS. (2021) Predictors of Veterans Health Administration utilization and pain persistence among soldiers treated for postdeployment chronic pain in the Military Health System. BMC Health Services Research, 21(1): 494.  PMCID: PMC8145830 

Adams RS, Corrigan JD, Ritter GA, Hagemeyer A, Pliskin MB, Reif S. (2021). Association of Lifetime History of Traumatic Brain Injury with Prescription Opioid Use and Misuse among Adults. Journal of Head Trauma Rehabilitation, 36(5):328-337.

Adams RS. (2021). Traumatic Brain Injury and Opioid Use: Additional Evidence Supporting the “Perfect Storm” of Cascading Vulnerabilities. Preface to the Topical Issue on Traumatic Brain Injury and Opioids in Journal of Head Trauma Rehabilitation, 36(5):303-309.

Adams RS, Ketchum JM, Nakase-Richardson R, Katz DI, Corrigan JD. (2021). Prevalence of Drinking within Low-Risk Guidelines during the First Two Years Following Inpatient Rehabilitation for Moderate or Severe Traumatic Brain Injury. American Journal of Physical Medicine & Rehabilitation, 100(8):815-819. 

Adams RS, Jiang T, Rosellini AJ, Horvath-Puho E, Street AE, Keyes KM, Cerda M, Lash TL, Sorensen HT, Gradus JL. (2021) Sex-Specific Risk (10):2882-2892. PMCID: PMC8459184.    

Alford DP., Kim, TW, Samet JH, Cruz AB, Brolin MF, Shanahan CW, Saitz R. Prevalence and Correlates of Positive Follow-up Screens in Primary Care for Unhealthy Alcohol and Other Drug Use After a Negative Screen. Journal of Addiction Medicine, Nov 2021.

Bauer MR, Larson MJ, Moresco N, Huntington N, Walker R, Richard P. (2021)   Association between 1-year patient outcomes and opioid-prescribing group of emergency department clinicians: A cohort study with Army active-duty soldiers. American Emergency Medicine, 28(11):1251-1261.

Bohler R, Hodgkin D, Kreiner P, Green TC. (2021)  Predictors of US States’ Adoption of Naloxone Access Laws, 2001-2017.  Drug and Alcohol Dependence, 225:108772.  PMCID: PMC8282714

Bohler R, Thomas CP, Clark TW, Horgan CM. (2021). Addressing the Opioid Crisis through Social Determinants of Health: What Are Communities Doing? Opioid Policy Research Collaborative at Brandeis University.  

Corrigan, JD, Adams, RS, and Dams-O’Connor, K. (2021) (Forthcoming). At-Risk Substance Use and Substance Use Disorders. Brain Injury Medicine: Principles and Practice, Third Edition. Eds. Zasler ND, Katz DI, Zafonte RD. New York: Springer Publishing Company, LLC., 1241-125.

Davis MT, Torres ME, Ngyuen A, Stewart MT, Reif S. (2021) Improving quality and performance in substance use treatment programs: What is being done and why is it so hard? Journal of Social Work, 21(2):141-161.  PMCID: PMC7971453  

Delcher C, Harris DR, Park C, Strickler GK, Talbert J, Freeman PR. (2021) Doctor and pharmacy shopping: A fading signal for prescription opioid use monitoring? Drug and Alcohol Dependence, 221:108618. PMCID: PMC8026641

Elliott L, Crasta D, Khan M, Roth A, Green TC, Kolodny A, Bennett AS. (2021) Validation of the Opioid Overdose Risk Behavior Scale, version 2 (ORBS-2). Drug and Alcohol Dependence, 223:108721. PMCID: PMC8113089

Formica SW, Waye KM, Benintendi AO, Yan S, Bagley SM, Beletsky L, Carroll JJ, Xuan Z, Rosenbloom D, Apsler R, Green TC, Hunter A, Walley AY. (2021)  Characteristics of post-overdose public health-public safety outreach in Massachusetts. Drug Alcohol Dependence, 219:108499.  

Gandhi P, Rouhani S, Park JN, Urquhart GJ, Allen ST, Morales KB, Green TC, Sherman SG. (2021)  Alternative Use of Buprenorphine Among People Who Use Opioids in Three U.S. Cities. Substance Abuse, 43(1):364-370.

 Goff SL, Gurewich D, Alcusky M, Kachoria AG, Nicholson J, Himmelstein J. (2021) Barriers and Facilitators to Implementation of Value-Based Care Models in New Medicaid Accountable Care Organizations in Massachusetts: A Study Protocol. Front Public Health, 9:645665. PMCID: PMC8055830

Gray JC, Larson MJ, Moresco N, Ritter GA, Dufour S, Milliken CS, Adams RS. (2021) The association of engagement in substance use treatment with negative separation from the military among soldiers with post-deployment alcohol use disorder. Drug and Alcohol Dependence, 221:108647.  PMCID: PMC8136466

Hodgkin D, Adams RS, Ritter G, Lee S, Highland KB, Larson MJ. (2021) Do nonpharmacological services offset opioids in pain treatment for soldiers? Health Services Research, 56(6):1222-1232. PMCID: PMC8586474.

Hodgkin D, Horgan CM, Bart G. (2021). Financial sustainability of payment models for office-based opioid treatment in outpatient clinics. Addiction Science & Clinical Practice, 16(1):45. PMCID: PMC8256208

Hodgkin D, Horgan CM, Stewart M, Brown SJ. (2021). New interventions to address substance use disorder must take financial sustainability into account. Health Affairs Blog. 

Hughto JMW, Case P, Palacios WR, Tapper A, Stopka TJ, Green TC. (2021) Understanding Opioid Overdose Risk and Response Preparedness among People who Use Cocaine and Other Drugs: Mixed-Methods Findings from a Large, Multi-City Study.  Substance Abuse, 43(1): 465-478. 

Irvine M, Oller D, Boggis J, Bishop B, Coombs D, Wheeler E, Doe-Simkins M, Walley A, Marshall BDL, Bratberg J, Green T. (2021) Estimating Naloxone Need in the United States Across Fentanyl. Heroin, and Prescription Opioid Epidemics: A Modelling Study. Lancet Public Health, 7(3):210-218.

Johnson JK, Jones AA, Hodgkin D, Kritikos AF, Harris SK, Johnson RM (2021). Medical marijuana laws (MMLs) and dispensary provisions not associated with higher odds of adolescent marijuana or heavy marijuana use: A 46 State Analysis, 1991-2015. Substance Abuse, 42(4): 471-475. PMCID: PMC8455699

Kaplowitz E, Truong AQ, Macmadu A, Peterson M, Brinkley-Rubinstein L, Potter N, Green TC, Clarke JG, Rich JD. (2021)  Fentanyl-related overdose during incarceration: a comprehensive review. Health and Justice, 9(1):13. PMCID: PMC8133055

Kritikos A, Johnson JK, Hodgkin D. (2021) Past 30-day marijuana vaping: Prevalence and predictors of use in a nationally representative study of U.S. youth. American Journal of Preventive Medicine, 60(2): 258-266. PMCID: PMC7854829

Kumar RG, Ornstein KA, Corrigan JD, Adams RS, Dams-O'Connor K. (2021) Association between Lifetime History of Traumatic Brain Injury, Prescription Opioid Use, and Persistent Pain: A Nationally Representative Study. Journal of Neurotrauma, 38(16):2284-2290. PMCID: PMC8672103.

Lee H, Porell F, Hodgkin D, Johnson M (2021).  Medicaid Expansion and Racial and Ethnic Disparities in Access to Health Care: Applying the National Academy of Medicine Definition of Health Care Disparities.  Inquiry 58:46958021991293. PMCID: PMC7878957

Mazel S, Zisman-Ilani Y, Hennig S, Garnick D, Nicholson J. (2021) Virtual Engagement on Social Media: Content analysis of an Online Community of mothers with substance use. JMIR Formative Research, 5(6):24353.  PMCID: PMC8277390

Nicholson J, English K, Heyman M. (2021) The ParentingWell learning collaborative feasibility study: Training adult mental health service practitioners in a family-focused practice approach. Community Mental Health Journal, 58(2):261-276.  PMCID: PMC8019525

Nicholson J.  Risks linked with parental mental illness and substance use are undeniable, but efforts to scale-out and sustain evidence-based practices are challenging. (2021) Frontiers Science News.

Nolen S, Zang X, Chatterjee A, Behrends CN, Green TC, Kumar A, Linas BP, Morgan JP, Murphy SM, Walley AY, Yan S, Schackman BR, Marshall BDL. (2021) Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island.Addiction, 117(5):1372-1381. PMCID: PMC8983544.

Powell RM, Nicholson J. (2021) Addressing risk factors among parents with serious mental illness: Commentary on Ostrow et al. Psychiatric Services, 72(4): 466-467.

Pugatch M, Chang G, Garnick D, Brolin M, Brief D, Miller C, Fleming J, Blaney D, Harward B, Hodgkin D. (2021). Rates and predictors of brief intervention for women veterans returning from recent wars: Examining gaps in service delivery for unhealthy alcohol use. Journal of Substance Abuse Treatment, 123: 108257. PMCID: PMC8191812

Reif S, Lauer EA, Adams RS, Brucker DL, Ritter GA, Mitra M. (2021) Examining Differences in Prescription Opioid Use Behaviors among U.S. Adults With and Without Disabilities. Preventive Medicine, 153:106754.

Reif S, Stewart MT, Dana BM, Torres ME, Davis MT, Ritter GA. (2021) Effectiveness of value-based purchasing for substance use treatment engagement and retention. Journal of Substance Abuse Treatment, 122:108217.  PMCID: PMC8380407

Richard P, Bowser D, Bauer MR, Moresco N, Walker, R, Reed D, Larson MJ. (2021) Opioid Prescribing for Surgical Dental Procedures in Dental Clinics of Military Treatment Facilities. Journal of American Dental Association, 152(2):94-104. PMCID: PMC8207621

Saadoun M, Bauer M, Adams RS, Highland K, Larson MJ. (2021) Opioid Non-pharmacologic and Pharmacologic Treatments for Soldiers with Chronic Pain and Posttraumatic Stress Disorder.  Psychiatric Services, 72(3):264-272. PMCID: PMC8127998

Santos P, Faughnan K, Prost C, Tschampl CA. (2O21). Systemic Barriers to
Care Coordination for Marginalized and Vulnerable Populations. Journal of Social
Distress and Homelessness. Published online Dec. 28, 2021.

Shields MC, Horgan CM, Ritter GA, Busch AB. (2021) Use of electronic health information technology in a national sample of hospitals that provide specialty substance use care. Psych Services, , 72(12):1370-1376. PMCID: PMC8517030. 

Starosta AJ, Adams RS, Marwitz J, Kreutzer, J, Monden KR, Dams-O’Connor K, Hoffman J. (2021). Scoping Review of Opioid Use after Traumatic Brain Injury. Journal of Head Trauma Rehabilitation, 36(5):310-327. 

Stewart MT, Coulibaly N, Schwartz D, Dey J, Thomas CP. (2021). Emergency department-based efforts to offer medication treatment for opioid use disorder: What can we learn from current approaches? Journal of Substance Abuse Treatment, 129:108479.  PMCID: PMC8380665

Talbert J, Bohler R, Frazier L, El-Bassel N, Freeman P. (2021) Letter to the Editor regarding: Medicaid prescription limits and their implications for naloxone accessibility (by Roberts et al., 2021). Drug and Alcohol Dependence, 226.  

Valentine A, Walker R, Nicholson J. (2021) Key considerations in building the organizational capacity to implement peer support for parents with mental illness. Advances in Mental Health, 20(1):26-37.

Warren EC, Kolodny A. (2021) Trends in Heroin Treatment Admissions in the United States by Race, Sex, and Age. JAMA Network Open, 4(2):2036640. PMCID: PMC7865191.

Wightman RS, Erowid E, Erowid F, Thyssen S, Wheeler M, Pulminskas B, Olson R, Green TC. (2021) Confirmed reports of bupropion sold as crack cocaine in the illicit drug supply. Clinical Toxicol (Phila) 59(11): 1031-1032.

Zang X, Macmadu A, Krieger MS, Behrends CN, Green TC, Morgan JR, Murphy SM, Nolen S, Walley A, Schackman BR, Marshall BD. (2021) Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island. International Journal of Drug Policy, 98:103435.

Zocchi MS, Robinson SA, Ash AS, Vimalananda VG, Wolfe HL, Hogan TP, Connolly SL, Stewart MT, Am L, Netherton D, Shimada SL. (2021) Patient Portal Engagement and Diabetes Management Among New Portal Users in the Veterans Health Administration. J Am Med Inform Assoc, 28(10):2176-2183. PMCID: PMC8449618

Adams RS, Campbell-Sills Laura, Stein MB, Sun X, Larson MJ, Kessler RC, Ursano RJ, Jain S,  Corrigan JD, (2020) The Association of Lifetime and Deployment-Acquired Traumatic Brain Injury With Postdeployment Binge and Heavy Drinking, Journal of Head Trauma Rehabilitation,  35(1):27-36. PMCID: PMC6940520 .

Adams RS, Garnick DW, Harris AH, Merrick EL, Larson MJ (2020) Assessing the postdeployment quality of treatment for substance use disorders among Army enlisted soldiers in the Military Health System. J of Substance Abuse Treatment, 114:108026. PMCID: PMC7367624

Adams RS, Corrigan JD, Dams-O’Connor K. (2020) Opioid Use Among Individuals with Traumatic Brain Injury: A Perfect Storm? Journal of Neurotrauma, 37(1):211-216. PMCID: PMC7364315

Adams RS, Dietrich EJ, Gray JC, Milliken CS, Moresco N, Larson MJ. Post deployment screening in the military health system: An opportunity to intervene for possible alcohol use disorder. Health Affairs, 358(8):1298-1306.  PMCID: PMC7357622

Adams RS, Corrigan JD, Dams-O’Connor K, Reif, S. (2020) Opioid Use Among People With Traumatic Brain Injury (Main and Plain-Language Versions). INROADS Issue Brief. Waltham, Mass., Institute for Behavioral Health, the Heller School for Social Policy and Management, Brandeis University.

Brenner, LA, Otis, J, Grassmeyer, RP, Adams, RS, Laker, SR, & Filley, CM. (2020). Assessment and Management of Psychiatric Symptoms among Adults with Mild Traumatic Brain Injury. Concussion: Assessment, Management and Rehabilitation. Eds. Blessen C. Eapen, MD., David X. Cifu, MD. Elsevier, Inc., 47-58.

Burstein D, J Baird, E Donovan, P Case, Soipe A, Tapper A, Walley AY, Bratberg J, Green TC. (2020) Pharmacist attitudes toward pharmacy-based naloxone, a cross-sectional survey study. Journal of the American Pharmacists Association, 60(2):304-310.   

Busch AB, Greenfield SF, Reif S, Normand SLT, Huskamp H. (2020) Outpatient care for opioid use disorder among the commercially insured: use of medication and psychosocial treatment. Journal of Substance Abuse Treatment, 115:108040.  PMCID: PMC7687676

Carroll JJ, Mital S, Wolff J, Noonan RK, Martinez P, Podolsky MC, Killorin JC, Green TC. (2020) Knowledge, Preparedness, and Compassion Fatigue among Law Enforcement Officers Who Respond to Opioid Overdose. Drug and Alcohol Dependence, 217:108257. PMCID: PMC7475730   

Davis MT, Warfield ME, Boguslaw J, Roundtree-Swain D, Kellogg G. (2020). Parenting a 6-Year-Old Is Not What I Planned in Retirement: Trauma and Stress Among Grandparents Due to the Opioid Crisis. Journal of Gerontological Social Work, 63(4): 295-315.

Donovan E, Baird J, Burstein D, Case P, Walley AY, Bratberg J, Green TC. (2020) Pharmacy leaders’ beliefs about how pharmacies can support a sustainable approach to providing naloxone to the community. Research in Social and Administrative Pharmacy, 16(10):1493-1497.

Dufour, SC, Adams, RS, Brody, DL, Puente, AN, and Gray, JC. (2020) Prevalence and Correlates of Concussion in Children: Data from the Adolescent Brain Cognitive Development Study. Cortex, 131: 237-250.

Garnick DW, Horgan CM, Acevedo A, Lee MT, Panas L, Ritter GA, Campbell K. (2020). Rural clients' continuity into follow-up substance use disorder treatment: impacts of travel time, incentives, and alerts. Journal of Rural Health, 36(2):196-207. PMCID: PMC6856385

Gaur DS, Jacka BP, Green TC, Samuels EA, Hadland SE, Krieger MS, Yedinak JL, Marshall BDL. (2020) US Drug Overdose Mortality: 2009–2018 Increases Affect Young People Who Use Drugs. Int J Drug Policy, 85:102906. PMCID: PMC7769862    

Green TC (Technical Expert Panel Member). (2020)  Prevention and Treatment of HIV Among People Living with Substance Use and/or Mental Disorders. This  guide reviews interventions for people living with substance use and mental disorders who are at risk for or living with HIV. Selected interventions are in alignment with goals of the federal “Ending the HIV Epidemic: A Plan for America” (EHE) initiative. SAMHSA Publication ID PEP20-06-03-001.   

Green TC, Bratberg J, Baird J, Burstein D, Lenz K, Case P, Walley AY, Xuan Z. (2020) Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy. Int J Drug Policy, 85:102602.  

Green TC, Soipe A, Baoy B, Burstein D, Xuan Z, Tapper A, Walley AY, Case P,  Bratberg J, Baird J. (2020) Pharmacy on-site overdose protocols and prevention of overdose. Substance Abuse.

Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, Clarke W, Sherman SG. (2020) An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. International Journal of Drug Policy, 77:102661.

Green TC, Soipe A, Baloy B, Burstein D, Xuan Z, Tapper A, Walley AY, Case P, Bratberg J, Baird J. (2020) Pharmacy on-site overdose protocols and prevention of overdose. Substance Abuse. Published online, DOI: 10.1080/08897077.2020.1736236

Green TC, C Davis, Z Xuan, AY Walley, J Bratberg. (2020)  Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014–2018.  American Journal of Public Health, 110(6):881-887. PMCID: PMC7204438

Green TC, Donovan E, Klug B, Case P, Baird J, Tapper A, Walley A, Bratberg J. (2020)  Revisiting pharmacy-based naloxone with pharmacists and naloxone consumers in two states: 2017 perspectives and evolving approaches.  Journal of the American Pharmacists Association, 60(5):740-749.  

Hall OT, Hall OE, Kolodny A, Teater J, McGrath RP  (2020) Assessment of Excess Mortality Associated With Drug Overdose in Ohio From 2009 to 2018. JAMA  Network Open, 3(4):e202183.  PMCID: PMC7139273

Hackman HH, McDonald J, Koziol J, Green TC. (2020) Multidisciplinary team reviews of drug overdose deaths and the use of mini-grants to advance recommendations:  A statewide pilot in Rhode Island. Journal of Public Health Management & Practice, 26(3):236-242.

Hodgkin D, Moscarelli M, Rupp A Zuvekas SH  (2020)  Mental health economics: bridging research, practice and policy. World Psychiatry 19(2):258-259. PMCID: PMC7215076

Hodgkin D, Garnick DW, Horgan CM, Busch AB, Stewart MT, Reif S. (2020) Is it feasible to pay specialty substance use disorder treatment programs based on patient outcomes? Drug Alcohol Depend, 206:107735.  PMCID: PMC6941579.  

Huskamp H, Reif S, Greenfield SF, Normand SL, Busch AB. (2020) Medication Utilization for Alcohol Use Disorder in a Commercially Insured Population. Journal of General Internal Medicine, 35(11):3262–3270.  PMCID: PMC7661665

Imm P, Brolin M, Yost J, Stone O. (2020) Empowerment Evaluation. In Kilmer RP, and Cook JR. (eds.) The Practice of Evaluation: Partnership Approaches for Community Change.  Thousand Oaks, CA., Sage Publications.

Irvine M, Coombs D, Skarha J, del Pozo B, Rich J, Taxman F, Green TC. (2020) Modeling COVID-19 and impacts on U.S. Immigration and Customs Enforcement (ICE) detention facilities, 2020.  Journal of Urban Health, 97(4):439-447. PMCID: PMC7228433

Junqing L, Storfer-Isser A, Mark TL, Oberlander T, Horgan CM, Garnick DW, Scholle SH (2020). Access to and engagement in substance use disorder treatment over time. Psychiatric Services, 71(7):722-725.

Kachoria A, Leary A, Miller F, Sefton LA, Nicholson J, Himmelstein J. (2020). Improving Care Coordination between Accountable Care Organizations and Community Partners: Early Findings from the Massachusetts Delivery System Reform Incentive Payment (DSRIP) Program. University of Massachusetts Medical School Publications. 

Kolodny A. (2020) Guidelines on the Management of Chronic Pain in Children. Geneva, Switzerland: World Health Organization; ISBN-13: 978-92-4-001787-0

Kolodny A. (2020) How FDA Failures Contributed to the Opioid Crisis. AMA J Ethics, 22(1):E743-750.  

Lee MT, Torres M, Brolin M, Merrick EL, Ritter GA, Panas L, Horgan CM, Lane N, Hopwood JC, De Marco N,  Gewirtz A. (2020). Impact of recovery support navigators on continuity of care after detoxification. Journal of Substance Abuse Treatment, 112:10-16.

Macmadu A, Goedel WC, Adams JW, Brinkley-Rubinstein L, Green TC, Clarke JG, Martin RA, Rich JD, Marshall BDL. (2020)  Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails. Drug and Alcohol Dependence, 208:107858. PMCID: PMC7075016      

McDaniel JM, Brown AM, Heller AT, Johnston TW, Bergman BG, Bohler R, (2020) Interdisciplinary Expansions: Applying Recovery-Informed Theory to Interdisciplinary Areas of Recovery Science Research. Alcoholism Treatment Quarterly, 38(4).

Meerwijk EL, Larson MJ, Schmidt EM, Adams RS, Bauer MR, Ritter GA, Harris AH. (2020). Nonpharmacological Treatment of Army Service Members with Chronic Pain Is Associated with Fewer Adverse Outcomes After Transition to the Veterans Health Administration. Journal of General Internal Medicine, 35(3):775-783. PMCID: PMC7080907

Nicholson J, de Girolamo G, Schrank B. (Eds.). (2020) Editorial: Parents With Mental and/or Substance Use Disorders and Their Children. Frontiers in Psychiatry, 10:915. PMCID: PMC6916660

Powell RM, Mitra M, Nicholson J, Parish SL. (2020). Perceived community-based needs of low-income parents with psychiatric disabilities who experienced legal challenges to their parenting rights. Children and Youth Services Review, 112.

Powell RM, Parish SL, Mitra M, Nicholson J. (2020). Responding to the legal needs of parents with psychiatric disabilities: Insights from parent interviews. Law & Inequality: A Journal of Theory and Practice, The University of Minnesota, XXXVIII, 69-114.

Reif S, Brolin M, Stewart MT, Mazel S, Speaker L, Fuchs T. (2020) The Washington State hub and spoke model to expand access to medication treatment for opioid addiction. Journal of Substance Abuse Treatment 2020; 108:33-39. PMCID: PMC6893117.

Reif S, Adams RS, Ritter GA, Larson MJ (2020) Exploration of the association of selected pain diagnoses with risky alcohol use among active duty soldiers. Substance Abuse, 41(4):456-462. PMCID: PMC7199522

Rouhani S, Park JN, Morales KB, Green TC, Sherman SG. (2020) Trends in opioid initiation among people who use opioids in three US cities. Drug Alcohol Rev. 39(4):375-383.  

Stewart MT, Hogan TP, Nicklas J, Robinson SA, Purington CM, Miller CJ, Vimalananda VG, Connolly SL, Wolfe HL, Nazi KM, Netherton D, Shimada SL. (2020). The promise of patient portals for individuals living with chronic illness: Qualitative study identifying pathways of patient engagement. Journal of Medical Internet Research. 22(7) e17744.

Stone A, Carroll J, Rich J, Green TC. (2020) One year of Methadone Maintenance Treatment in a Fentanyl Endemic Area: Safety, Repeated Exposure, Retention, and Remission. Journal of Substance Abuse Treatment, 115:108031. 

Strickler GK, Kreiner PW, Halpin JF, Doyle E, Paulozzi LJ. (2020) Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010–2016. U.S. Department of Health and Human Services/Center for Disease Control and Prevention. Morbidity and Mortality Weekly Report, Surveillance Summaries, 69(1):1-14. PMCID: PMC7011442

Torres M, Brolin M, Panas L, Ritter G, Hodgkin D, Lee M, Merrick, EL, Horgan C, Hopwood JC, Gewirtz A, De Marco N, Lane N. (2020) Evaluating the feasibility and impact of case rate payment for recovery support navigator services: a mixed methods study. BMC Health Services Research, 20(1):1004.  PMCID: PMC7607694 

Wakeman SE, Green TC, Rich J. (2020). An Overdose Surge Will Compound the COVID-19 Pandemic If Urgent Action Is Not Taken. Nature Medicine, 26(6): 819-820.

Acevedo A, Miles J, Garnick DW, Panas L, Ritter G, Campbell K, Acevedo-Garcia D. (2019) Employment After Beginning Treatment for Substance Use Disorders: The Impact of Race/Ethnicity and Client Community of Residence. Journal of Substance Abuse Treatment, 87: 31-41. PMCID: PMC5830150

Adams RS, Corrigan JD, with contributions from Brolin M, Gardiner F, Mitra M, Nicholson J, Reif S. (2019) Intersection Between Traumatic Brain Injury and Opioid Use disorder: Recommendations for Substance Use Treatment Providers. Fact sheet for the National Institute on Disability, Independent Living, and Rehabilitation Research, Administation for Community Living, U.S. Department of Health and Human Services. 

Adams RS, Corrigan JD, Reif S. (2019) Intersection between traumatic brain injury and opioid use disorder recommendations for substance use treatment providers. INROADS Project Issue Brief, April 2019. Brandeis University, Waltham, MA.   

Adams, RS, and Corrigan, JD. (2019) Is Moderate Drinking Safe After Traumatic Brain Injury? Brain Injury Professional: Brain Injury as a Chronic Condition Current State of the Knowledge. 16(3):24.

Adams RS, Corrigan JD, Dams-O'Connor D. (2019) Opioid Use among Individuals with Traumatic Brain Injury: A Perfect Storm?. Journal of Neurotrauma, 37(1):211-216.  PMCID: PMC7364315

Adams RS, Dietrich EJ, Gray JC, Milliken CS, Moresco N, Larson MJ. (2019) Post-Deployment Screening in the Military Health System: An Opportunity to Intervene for Possible Alcohol Use Disorder. Health Affairs, 38(8):1298-1306. PMCID: PMC7357622

Adams RS, Thomas CP, Ritter GA, Lee S, Saadoun M, Williams TV, Larson MJ. (2019) Predictors of Postdeployment Prescription Opioid Receipt and Long-term Prescription Opioid Utilization Among Army Active Duty Soldiers. Military Medicine, 184(1-2):e101-e109. PMCID: PMC6329665

Adams RS, Larson MJ, Meerwijk EL, Williams TV, Harris AHS. (2019) Postdeployment Polytrauma Diagnoses among Soldiers and Veterans using the Veterans Health Affairs Polytrauma System of Care and Receipt of Opioids, Nonpharmacologic, and Mental Health Treatments. Journal of Head Trauma Rehabilitation, 34(3):167-175. PMCID: PMC6546163

Betthauser LM, Adams RS, Hostetter T, Scher AI, Schwab K, Brenner, LA. (2019). Characterization of Lifetime TBIs in a Cohort of Recently Deployed Soldiers: The Warrior Strong Study. Rehabilitation Psychology. 64(4), 398–406.

Bohler, R., Doonan, M., Horgan, C. (2019). Addressing the Opioid Crisis in Small and Rural Communities in Western Massachusetts. Massachusetts Health Policy Forum.  

Bowser D, Henry BF, McCollister KE. (2019) An Overlapping Systems Conceptual Framework to Evaluate Implementation of a Behavioral Health Intervention for Justice-involved Youth. Health Services Insights, 12:1-12.PMCID: PMC6582281

Brolin M. (2019) Massachusetts State Youth Treatment & Implementation Project: Final Evaluation Report. Office of Youth and Young Adult Services, Bureau of Substance Addiction Services, Massachusetts Department of Public Health.

Brolin M. (2019) Project Peer Connection: Final Evaluation Findings - October 2015 to May 2019. Spectrum Health Systems, Inc.

Corrigan JD, Adams RS. (2019) The Intersection of Lifetime History of Traumatic Brain Injury and the Opioid Epidemic. Addictive Behaviors, 90:143-145. PMCID: PMC6496936

Davis MT, Torres M, Nguyen A, Stewart MT, Reif S. (2019) Improving Quality and Performance in Substance Use Treatment Programs: What is Being Done and Why is it So Hard? Journal of Social Work, 21(2):141-161. PMCID: PMC7971453 

Foster K, Goodyear M, Grant A, Weimand B, Nicholson J. (2019) Family-focused Practice, with EASE: A Practice Framework for Strengthening Relational Recovery when Mental Health Consumers are Parents. International Journal of Mental Health Nursing, 28(1):351-360.  

Garnick D, Horgan C, Mark TL, Lee M, Acevedo A, Neager S, O'Brien P, Hashmi A, Marder B, Miller K. (2019) The Importance of Identification When Measuring Performance in Addiction Treatment. Substance Abuse, 40(3):263-267. PMCID: PMC6763371  

Hoang PT, Hodgkin D, Thomas JP, Ritter G, Chilingerian J (2019). Effect of Periodic Health Exam on Provider Management of Preventive Services. Journal of Evaluation in Clinical Practice 25(5): 827-833.

 Hodgkin D, Gao W, Larson MJ, Drebing CE, Merrick EL, Pugatch M, Horgan CM, Zolotusky G, Petry NM, Saitz R. Referral to treatment after positive screens for unhealthy drug use in an outpatient Veterans Administration setting. Journal of Addiction Medicine, 14(3):236-243. PMCID: PMC7075731

Hodgkin D, Garnick DW, Horgan CM, Busch AB, Stewart MT,  Reif S. (2019). Is it feasible to pay specialty substance use disorder treatment programs based on patient outcomes? Drug and
Alcohol Dependence, 206:107735.  PMCID: PMC: 6941579   

Hodgkin D, Brolin MF, Ritter GA, Torres ME, Merrick EL, Horgan CM, Hopwood JC, De Marco N, Gewirtz A. (2019) Cost Savings From a Navigator Intervention for Repeat Detoxification Clients. Journal of Mental Health Policy and Economics, 22(1):3-13. 

Hostetter T, Hoffmire C, Forster J, Adams RS, Stearns-Yoder K, Brenner LA. (2019). Suicide and Traumatic Brain Injury Among Individuals Seeking Veterans Health Administration Services Between Fiscal Years 2006 to 2015. Journal of Head Trauma Rehabilitation. 34(5), E1-E9.

Kim, H., Keating, N.L., Perloff, J.N., Hodgkin, D., Liu, X., and Bishop, C.E. (2019). Aggressive Care Near the End of Life for Cancer Patients in Medicare Accountable Care Organizations. Journal of the American Geriatrics Society. 67(5), pp. 961-968. 

Kim, H., Bishop, C.E., Keating, N.L., Hodgkin, D., and Perloff, J.N. (2019). Reply to Including Palliative Care in the Assessment of Accountable Care Organizations for End-of-Life Care. Journal of the American Geriatrics Society, 67(8): 1759.  

Lee MT, Acevedo A, Garnick DW, Horgan CM, Panas L, Ritter GA, Campbell K. (2019) Impact of Agency Incentives and Reminders on Engagement and Care Continuity for Clients with Co-occurring Disorders. Psychiatric Services, 69(7):804-811. PMCID: PMC6193487

Mazel S, Hennig S, Zisman Ilani Y, Nicholson J. Mothers, Mental Health and Opioids: Engaging with Researchers @research4moms.com.  (2019) Journal of Parent and Family Mental Health, 4(1).   

Muench, U., Guo, C., Thomas, C.P., and Perloff, J.N. (2019). Medication Adherence, Costs, and ER Visits of Nurse Practitioner and Primary Care Physician Patients: Evidence From Three Cohorts of Medicare Beneficiaries. Health Services Research. 54(1), pp. 187-197 .  PMCID: PMC6338303 

Namkung EH, Mitra M, Nicholson J. (2019) Do Disability, Parenthood, and Gender Matter for Health Disparities?: A US Population-based Study. Disability and Health Journal, 12(4):594-601.

Nicholson J, English K. (2019) ParentingWell Practice Profile. Waltham, MA, National Research Center for Parents with Disabilities, the Heller School for Social Policy and Management, Brandeis University; and the Massachusetts Department of Mental Health. 

Nicholson J, English K. (2019) ParentingWell Workbook. Waltham, MA, National Research Center for Parents with Disabilities, the Heller School for Social Policy and Management, Brandeis University; and the Massachusetts Department of Mental Health. 

Nicholson J, Lee MT, Rao J, with contributions from Adams RS, Brolin M, Gardiner F, Mitra M, Reif S. (2019) Peer Support for People with Substance Use Disorders. Fact sheet: for the National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, U.S. Department of Health and Human Services.

Nicholson J, Valentine A. (2019) Key Informants Specify Core Elements of Peer Supports for Parents with Serious Mental Illness. Frontiers of Psychiatry, 10:106. PMCID: PMC6409303

Nicholson J, de Girolamo G, Schrank B. (2019). Parents With Mental and/or Substance Use Disorders and Their Children. Frontiers in Psychiatry. 10:915. PMCID: PMC6916660

Nicholson J, Lee MT, Rao J, Reif S. (2019) Connecting people with disabilities and opioid use disorder to technology-based peer support. INROADS Issue Brief, December 2019. Brandeis University.  

Powell R, Nicholson J. (2019) Disparities in Child Protective Services: Commentary on Kaplan et al. Psychiatric Services, 70(3):209-210.

Reif S, Brolin MF, Stewart MT, Fuchs TJ, Speaker E, Mazel S. (2019) The Washington State Hub and Spoke Model to Increase Access to Medication Treatment for Opioid use Disorders. Journal of Substance Abuse Treatment, 108:33-39. PMCID: PMC6893117

Reif S, Thomas CP, Valentine A, Gardiner F, with contributions from Adams RS, Brolin M, Mitra M, Nicholson J. (2019) Opioid Use Disorder Among People With Disabilities: Fact sheet - medication treatment. Fact sheet for the  National Institute on Disability, Independent Living and Rehabilitation Research, Administration for Community Living, U.S. Department of Health and Human Services. 

Reif S, Adams RS, Ritter GA, Larson MJ. Exploration of the association of selected pain diagnoses with risky alcohol use among active duty soldiers. Substance Abuse, 41(4):456-462. PMCID: PMC7199522

Snow JC, Tang X, Nakase-Richardson R, Adams RS, Wortman KM, Dillahunt-Aspillaga C, Miles SR. (2019) The Relationship Between PTSD Symptoms and Social Participation in Veterans with TBI: A VA TBIMS Study. Journal of Applied Rehabilitation Counseling, 50(1):41-56.

Stewart MT, Shields M, Mulvaney-Day N, O’Brien M. (2019) State Residential Treatment for Behavioral Health Conditions: Regulation and Policy. Report for the Office of the Assistant Secretary for Planning and Evaluation.  

Strickler GK, Zhang K, Halpin JM, Bohnert ASB, Baldwin G, Kreiner PW. (2019) Effects of Mandatory Prescription Monitoring Program (PDMP) Use Laws on Prescriber Registration and Use and on Risky Prescribing.  Drug and Alcohol Dependence, 199:1-9. 

Acevedo A, Miles J, Garnick DW, Panas L, Ritter G, Campbell K, Acevedo-Garcia D. (2018). Employment after beginning treatment for substance use disorders: The impact of race/ethnicity and client community of residence. Journal of Substance Abuse Treatment, 87:31-41. PMCID: PMC5830150 

Brown AB, Bohler R. (2018). Achieving a Fifteen Percent Relapse Rate: A Review of the Literature of Collegiate Recovery and Physician Health Program Data. Alcoholism and Treatment Quarterly. 37(1), 109-122.

Foster K, Goodyear M, Grant A, Weimand B, Nicholson J. (2018) Family-focused Practice with EASE: A Practice Framework for Strengthening Relational Recovery When Mental Health Consumers are Parents. International Journal of Mental Health Nursing, 28(1):351-360.

Hoang PT, Hodgkin D, Thomas JP, Ritter G, Chilingerian J. (2018). Effect of Periodic Health Exam on Provider Management of Preventive Services. Journal of Evaluation in Clinical Practice. DOI: 10.1111/jep.13083. Epub ahead of print.

Hodgkin D, Stewart MT, Merrick EL, Zhang Y, Deckersbach T, Nierenberg AA. (2018). Prevalence and Predictors of Physician Recommendations for Medication Adjustment in Bipolar Disorder Treatment. Journal of Affective Disorders, 238:666-673.

Hodgkin D, Connery HS. (2018). Effectiveness and availability of treatment for substance use disorders. In Oxford Research Encyclopedia of Economics and Finance. Oxford University Press. DOI: 10.1093/acrefore/9780190625979.013.103

Hodgkin D, Horgan CM, Stewart MT, Quinn AE, Creedon TB, Reif S, Garnick DW. (2018). Federal parity and access to behavioral health care in private health plans. Psychiatric Services, 69(4):396-402. PMCID: In process.

Hodgkin D, Gao W, Merrick EL, Drebing CE, Larson MJ, Horgan CM, Sharma M, Petry NM, Saitz R. (2018) Implementing single-item screening for drug use in a Veterans Health Administration outpatient setting. Substance Abuse, 39(4):410-418. PMCID: PMC6163096

Kolodny A, Frieden TR. (2018). Government Actions to Curb the Opioid Epidemic—Reply. Journal of the American Medical Association, 17;319(15):1620-1621.  

Larson MJ, Browne C, Nikitin RV, Wooten NR, Ball S, Adams RS, Barth K. (2018) Physicians report adopting safer opioid prescribing behaviors after academic detailing intervention. Substance Abuse, 2:1-7. PMCID: PMC6237655

Larson MJ, Adams RS, Ritter GA, Linton A, Saadoun M, Bauer MR. (2018). Associations of early treatments for low back pain with military readiness outcomes. Journal of Alternative and Complementary Medicine, 24(7):666-676. PMCID: PMC6065526

Lee MT, Acevedo A, Garnick DW, Horgan CM, Panas L, Ritter GA, Campbell K. (2018). Impact of agency incentives and reminders on engagement and care continuity for clients with co-occurring disorders. Psychiatric Services, 69(7):804-811. PMCID: PMC6193487

Nicholson, J., Wright, S., Carlisle, A., Sweeney, M.A., McHugo, G. J. (2018) The WorkingWell Smartphone App for Individuals with Serious Mental Illnesses: Proof-of-Concept, Mixed-Methods Feasibility Study. Journal of Medical Internet Research  Mental Health, 5(4), e11383. doi:10.2196/11383.

Nicholson J, Valentine A. (2018) Defining "peerness": Developing peer supports for parents with mental illnesses. Psychiatric Rehabilitation Journal, 41(2):157-159.

Nicholson J, Wright SM, Carlisle AM. (2018) BMJ Open. Pre-post, mixed-methods feasibility study of the WorkingWell mobile support tool for individuals with serious mental illness in the USA: a pilot study protocol. British Medical Journal Open, 8(2):e019936. PMCID: PMC5829935

Reif S, Adams RS, Ritter GA, Williams TV, Larson, MJ. (2017). Prevalence of pain diagnoses and burden of pain among active duty soldiers, FY2012. Military Medicine, 83(9-10):e330–e337.

Sonik RA, Parish SL, Mitra M, Nicholson J. (2018).  Parents With and Without Disabilities: Demographics, Material Hardship, and Program Participation. Review of Disability Studies: An International Journal, 14(4). [online version 01 December 2018]

Stewart MT, Reif S, Dana B, Nguyen A, Torres ME, Davis MT, Ritter GR, Hodgkin D, Horgan CM. (2018) Incentives in A Public Addiction Treatment System: Effects on Waiting Time and Selection. Journal of Substance Abuse Treatment, 95:1-8. PMCID: PMC6324836

Stewart MT, Horgan CM, Hodgkin D, Creedon T, Quinn AE, Garito L, Reif S, Garnick DW. (2018). Behavioral health coverage under the Affordable Care Act: What can we learn from marketplace products? Psychiatric Services, 69(3):315-321. PMCID: PMC5832546    

Thomas CP, Ritter GA, Harris AHS, Garnick DW, Freedman K, Herbert B. Applying American Society of Addiction Medicine Performance Measures in Commercial Health Insurance and Services Data. Journal of  Addiction Medicine, 12(4):287-294.

Vanneman ME, Larson MJ, Chen C, Adams RS, Williams TV, Meerwijk E, Harris AHS. (2018).  Treatment of low back pain with opioids and non-pharmacologic treatment modalities for Army veterans. Medical Care, 56(10):855-861. PMCID: PMC6143345

Warfield ME, Adams RS, Ritter GA, Valentine A, Williams TV, Larson MJ. (2018). Health care utilization among children with chronic conditions in military families. Disability and Health Journal, 11(4):624-631. PMCID:PMC6345153

Adams RS, Corrigan JD, Mohr BA, Williams TV, Larson MJ. (2017). Traumatic brain injury and post-deployment binge drinking among male and female Army active duty service members returning from Operation Enduring Freedom/Operation Iraqi Freedom. Journal of Neurotrauma, 34(7):1457-1465. PMCID: PMC5385416 

Barth KS, Ball S, Adams RS, Nikitin RV, Wooten NR, Qureshi ZP, Larson MJ. (2017). Development and feasibility of an academic detailing intervention to improve prescription monitoring program use among physicians serving military members and veterans. Journal of Continuing Education in the Health Professions, 37(2):98-105. PMCID: PMC5521811  

Becker WC, Fenton BT, Brandt CA, Doyle EL, Francis J, Goulet JL, Moore BA, Torrise V, Kerns RD, Kreiner PW. (2017). Multiple sources of prescription payment and risky opioid therapy among veterans. Medical Care, 55(7,S1):S33-S36.

Brolin M, Torres M, Hodgkin D, Horgan C, Lee M, Merrick E, Gewirtz A, Straus J, Harrington J, Lane N. (2017). Implementation of client incentives within a recovery navigation program. Journal of Substance Abuse Treatment, 72: 25-31.

Brolin M, Yost J. How to stop prison’s revolving door: Worcester County reentry program shows promising results to reduce recidivism, save money. Commonwealth Magazine, May 29, 2017.

Davis MT, Bateman B, Avorn J. (2017). Educational outreach to opioid prescribers: The case for academic detailing. Pain Physician, 20(2S):S147-S151.

Garnick DW, Horgan CM, Acevedo A, Lee MT, Panas L, Ritter GA, Campbell K, Bean-Mortinson J. (2017). Influencing quality of outpatient SUD care: Implementation of alerts and incentives in Washington State. J Subst Abuse Treat, 82:93-101. PMCID: PMC5653287 

Garnick DW, Horgan CM, Merrick EL, Hodgkin D, Reif S, Quinn AE, Stewart MT, Creedon TB. (2017). Private health plans’ contracts with managed behavioral healthcare organizations. Journal of Behavioral Health Services and Research, 44,149–157.  PMCID: PMC4754164 

Hodgkin D, Reif S, Stewart MT, Mohr B, Horgan CM. (2017, March). Target attainability and provider response in pay-for-performance: Evidence from substance use disorder treatment. Journal of Mental Health Policy and Economics, 20:S15-S15. 

Idrisov B, Murphy SM, Morrill T, Saadoun M, Lunze K, Shepard D. (2017). Implementation of methadone therapy for opioid use disorder in Russia - a modeled cost-effectiveness analysis. Substance Abuse Treatment, Prevention, and Policy, 12(1):4. PMCID: PMC5248462

Johnson J, Hodgkin D, Harris SK. (2017). The design of medical marijuana laws and adolescent use and heavy use of marijuana: Analysis of 45 states from 1991 to 2011. Drug Alcohol Depend, 170:1-8. PMCID: PMC5183555

Johnson JK, Johnson RM, Hodgkin D, Jones AA, Matteucci AM, Harris SK. (2017). Heterogeneity of state medical marijuana laws and adolescent recent use of alcohol and marijuana: Analysis of 45 States, 1991-2011. Substance Abuse, 9:1-8. PMCID: PMC5891387

Kaadan IM, Larson MJ. (2017). Management of post-stroke depression in the Middle East and North Africa: Too little is known. Journal of the Neurological Sciences, 378:220-224.

Kolodny A, Frieden TR. (2017). Ten steps the federal government should take now to reverse the opioid addiction epidemic. JAMA, 318(16):1537-1538.     

Kreiner PW, Strickler GK, Undurraga EA, Torres ME, Nikitin RV, Rogers A. (2017). Validation of prescriber risk indicators obtained from prescription drug monitoring program data. Drug and Alcohol Dependence, 173(S1):S31-S38.

Lin DH, Lucas E, Murimi IB, Kolodny A, Alexander GC. (2017). Financial conflicts of interest and the Centers for Disease Control and Prevention’s 2016 Guideline for Prescribing Opioids for Chronic Pain. JAMA Internal Medicine, 177(3):427-428.  

Nakase-Richardson R, Stevens LF, Tang X, Lamberty GJ, Sherer M, Walker WC, Pugh MJ, Eapen BC, Finn JA, Saylors M, Dillahunt-Aspillaga C, Adams RS, Garofano JS. (2017). Comparison of the VA and NIDILRR TBI Model System cohorts. J Head Trauma Rehabil, 32(4):221-233.  

Quinn AE, Hodgkin D, Perloff JN, Stewart MT, Brolin M, Lane N, Horgan CM. (2017). Design and impact of bundled payment for detox and follow-up care. Journal of Substance Abuse Treatment, 82:113-121. PMCID: PMC5873976

Quinn AE, Reif S, Merrick EL, Horgan CM, Garnick DW, Stewart MT. (2017). How do private health plans manage specialty behavioral health treatment entry and continuing care? Psychiatric Services, 68(9):931-937.

Quinn AE, Stewart M, Brolin M, Horgan C, Lane N. (2017). Massachusetts substance use disorder treatment organizations' perspectives on the Affordable Care Act: Changes in payment, services, and system design. Journal of Psychoactive Drugs, 49(2):151-159. PMCID: PMC5701571

Reif S, Acevedo A, Garnick DW, Fullerton CA. (2017). Reducing behavioral health inpatient readmissions for people with substance use disorders: Do follow-up services matter? Psychiatric Services, 68(8):810-818. PMCID: PMC5895963 

Reif S, Creedon TB, Horgan CM, Stewart MT, Garnick DW. (2017). Commercial health plan coverage of treatment for selected opioid use disorders from 2003 to 2014. Journal of Psychoactive Drugs, 49(2):102-110. PMCID: PMC5861719

Schneider KG, Warfield ME, Joshi P, Ha Y, Hodgkin D. (2017). Insights into the black box of child care supply: Predictors of provider participation in the Massachusetts Child Care Subsidy System. Child and Youth Services Review, 79:148-159.

Stewart MT, Horgan CM, Quinn A, Garnick DW, Reif S, Creedon TB, Merrick EL. (2017). The role of health plans in supporting behavioral health integration. Administration and Policy in Mental Health and Mental Health Services Research, 44(6):967-977. PMCID: PMC5892205 

Thomas CP, Doyle E, Kreiner P, Jones CM, Dubenitz J, Horan A, Stein BD. (2017). Prescribing patterns of buprenorphine waivered physicians. Drug and Alcohol Dependence, 181:213-218.  

Vanneman ME, Harris AHS, Chen C, Adams RS, Williams TV, Larson MJ. (2017). Post-deployment behavioral health screens and linkage to the Veterans Health Administration for Army Reserve component members. Psychiatric Services, 68(8):803-809. PMCID: PMC5697977

Weiner SG, Baker O, Rogers AF, Garner C, Nelson LS, Kreiner PW, Schuur JD. (2017). Opioid prescriptions by specialty in Ohio, 2010-2014. Pain Medicine, 19(5):978-989.

Wooten NR, Adams RS, Mohr B, Jeffery DD, Funk W, Williams TV, Larson MJ. (July 2017). Pre-deployment year mental health diagnoses and treatment in deployed Army women. Administration and Policy in Mental Health and Mental Health Services Research, 44(4):582-594. PMCID: PMC5203968 

Young L, Kreiner PK, Panas L. (2017). Unsolicited reporting to prescribers of opioid analgesics by a state prescription drug monitoring program: An observational study with matched comparison group. Pain Medicine, 19(7):1396-1407.

Adams RS, Larson MJ, Corrigan JD, Ritter GA, Horgan CM, Bray RM, Williams TV. (2016). Combat-acquired traumatic brain injury, posttraumatic stress disorder, and their relative associations with post-deployment binge drinking. J Head Trauma Rehabil, 31(1):13-22. PMCID: PMC4395509

Adams RS, Nikitin RV, Wooten NR., Williams TV, Larson MJ. (2016). The association of combat exposure and with post-deployment behavioral health problems among US Army female enlisted members returning from Iraq or Afghanistan. Journal of Traumatic Stress, 29(4):356-64. PMCID:PMC5139677

Brolin M, Stewart MT, Evans B, Horgan CM. (2016). Reducing risky alcohol use: What health care systems can do. Issue Brief, published by the Massachusetts Health Policy Forum.

Carrow G, Clark TW, Eadie JL, Kreiner PW, Nikitin RV. (2016). Prescription drug monitoring programs: Evidence-based practice to optimize prescriber use. Washington, DC. Pew Charitable Trusts.

Hodgkin D, Merrick EL, O'Brien PL, McGuire TG, Lee S, Deckersbach T, Nierenberg AA. (2016). Testing for clinical inertia in medication treatment of bipolar disorder. J Affect Disord, 205:13-19. PMCID: PMC5048514

Horgan CM, Hodgkin D, Stewart MT, Quinn A, Merrick EL, Reif S, Garnick DW, Creedon TB. (2016). Health plans' early response to federal parity legislation for mental health and addiction services. Psychiatr Services, 67(2):162-8. PMCID:PMC4738051

Horgan CM, Stewart MT, Reif S, Garnick DW, Hodgkin D, Merrick EL, Quinn AE. (2016). Behavioral health services in the changing landscape of private health plans. Psychiatr Services, 67(6):622-9. PMCID:PMC4889503

Hwang CS, Turner LW, Kruszewski SP, Kolodny A, Alexander GC. (2016). Primary care physicians' knowledge and attitudes regarding prescription opioid abuse and diversion. Clin J Pain, 32(4):279-84.

Kolodny A. (2016). Chronic pain patients are not immune to opioid harms. J Pain Palliat Care Pharmacother, 30(4):330-331.  

Larson MJ, Mohr BA, Jeffery DD, Adams RS, Williams TV. (2016). Predictors of positive illicit drug tests after OEF/OIF deployment among Army enlisted service members. Mil Med, 181(4):334-42. PMCID: PMC5087103

Quinn AE, Reif S, Evans B, Creedon TB, Stewart MT, Garnick DW, Horgan CM. (2016). How health plans promote health IT to improve behavioral health care. Am J Manag Care, 22(12):810-815. PMCID: PMC5629964

Reif S, Horgan CM, Hodgkin D, Matteucci AM, Creedon TB, Stewart MT. (2016). Access to addiction pharmacotherapy in private health plans. J Subst Abuse Treat, 66:23-9. PMCID: PMC4879589

Reif S, Horgan CM, Kreiner P, Nikitin R. (2016). Behavioral health organizations’ current and future approaches to addressing the U.S. opioid crisis. Report prepared for the Association of Behavioral Health and Wellness, published online May 2016.

Shepard DS, Daley MC, Neuman MJ, Blaakman AP, McKay JR. (2016). Telephone-based counseling in substance abuse treatment: Economic analysis of a randomized trial. Drug and Alcohol Dependence, 159:109-16. PMCID: PMC4744476

Thomas CP, Hodgkin D, Levit K, Mark TL. (2016). Growth in spending on substance use disorder treatment services for the privately insured population. Drug and Alcohol Dependence, 160:143-50.

Wooten NR, Adams RS, Mohr BA, Jeffery DD, Funk W, Williams TV, Larson MJ. (2016). Pre-deployment year mental health diagnoses and treatment in deployed Army women. Adm Policy Ment Health, 44(4):582-594. PMICD: PMC5203968

Acevedo A, Garnick DW, Dunigan R, Horgan CM, Ritter G, Lee MT, Panas L, Bidorini A, Campbell K, Haberlin K, Lambert-Wacey D, Leeper T, Reynolds M, Wright D. (2015). Performance measures and racial/ethnic disparities in the treatment of substance use disorders. Journal of Studies on Alcohol and Drugs, 76: 57-67. PMCID:PMC4263781  

Adams RS, Larson MJ, Corrigan JD, Ritter GA, Horgan CM, Bray RM, Williams TV. (2016). Combat-acquired traumatic brain injury, Posttraumatic stress disorder, and their relative associations with postdeployment binge drinking. Journal of Head Trauma Rehabilitation, 31(1), pp.13-22. PMCID: PMC4395509

Brolin M, Dennehy K, Booxbaum A, Horgan C. (2015). Improving access to substance abuse treatment and reducing incarceration and recidivism. Prepared for the Massachusetts Health Policy Forum, November 2015. The brief was presented at the Massachusetts Health Policy Forum on November 17.

Garnick DW, Horgan CM, Merrick EL, Hodgkin D, Reif S, Quinn AE, Stewart MT, Creedon TB. (2015). Private health plans’ contracts with managed behavioral healthcare organizations. Journal of Behavioral Health Services & Research, 1:9. PMCID: PMC4754164

Hodgkin D, Horgan CM, Creedon TB, Merrick EL, Stewart MT. (2015). Management of newer antidepressant medications in U.S. commercial health plans. Journal of Mental Health Policy and Economics, 18:165-173. PMCID: PMC4812668

Hodgkin D, Thomas CP, O'Brien PL, Levit K, Richardson J, Mark TL, et al. (2015). Projected spending on psychotropic medications 2013-2020. Administration and Policy in Mental Health, 43(4):497-505.  

Horgan CM, Hodgkin D, Stewart MT, Quinn A, Merrick EL, Reif S, Garnick DW, Creedon TB. (2015). Health plans’ early response to federal parity legislation for mental health and addiction services. Psychiatric Services, 67(2):162-8. PMCID: PMC4738051

Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36:559-574. 

Larson MJ, Mohr BA, Adams RS, Williams TV. (2015). The association of deployment and behavioral health problems with positive drug tests among Army members returning from Iraq or Afghanistan. Addiction Science and Clinical Practice, 10(Supp 1):A31. PMCID: PMC4347455  

Merrick EL, Hodgkin D, Horgan CM, Lorenz L, Panas L, Ritter G, Kasuba P, Poskanzer D, Altman-Nefussy R. (2015). Testing novel patient financial incentives to increase breast cancer screening. American Journal of Managed Care, 21(11):771-779.

Miller DP, Larson MJ, Devoe E. (2015). Food insecurity in veteran households - Findings from nationally representative data. Public Health Nutrition, 19(10):1731-40. 10, pp.1-10.

Paulozzi LJ, Strickler GK, Kreiner P, Koris CM. (2015). Controlled substance prescribing patterns - Prescription Behavior Surveillance System, eight states, 2013. MMWR Surveillance Summary, Oct 16; 64(9):1-14.

Shepard DS, Gurewich D, Lwin AK, Reed, Jr., GA, Silverman, MD, MM. (2015). Suicide and suicidal attempts in the United States: Costs and policy implications. Suicide and Life-Threatening Behavior, 46(3):352-62.  PMCID: PMC5061092

Vanneman ME, Harris AS, Chen C, Mohr B, Adams RS, Williams TV, Larson MJ. (2015). Army active duty members’ linkage to Veterans Health Administration Services after deployments to Iraq or Afghanistan and following separation. Military Medicine, 180(10):1052-1058. PMCID: PMC4625796.

Wilmoth MC, Linton A, Gromadzki R, Larson MJ, Williams TV, Woodson J. (2015). Factors associated with psychiatric evacuation among Service members deployed to Operation Enduring Freedom and Operation Iraqi Freedom. January 2004 – September 2010. Military Medicine, 180(1):53-60. 

Zhu J, Weingart SN, Ritter GA, Tompkins CP, Garnick DW. (2015). Racial/Ethnic disparities in patient experience with communication in hospitals: Real differences or measurement errors? Medical Care, 53(5):446-454.

2014

Adams RS, Larson MJ, Corrigan JD, Ritter GA, Horgan CM, Bray RM, Williams TV. (2014). Combat-acquired traumatic brain injury, posttraumatic stress disorder, and their relative associations with post-deployment binge drinking. Journal of Head Trauma Rehabilitation, 31(1):13-22. PMCID:PMC4395509

Davis MT. (2014). Religious and non-religious components in substance abuse treatment: A comparative analysis of faith-based and secular interventions. Journal of Social Work, 14(3): 243-259

Davis MT, Mulvaney-Day N, Larson MJ, Hoover R, Mauch D. (2014). Complementary and alternative therapies among military personnel, an analysis of population surveys. Med Care, 52(12 Suppl 5), S83-90. 

Dunigan R, Acevedo A, Campbell K, Garnick DW, Horgan CM, Huber A, Lee MT, Panas L, Ritter G. (2014). Engagement in outpatient substance abuse treatment and employment outcomes. Journal of Behavioral Health Services & Research, 41:20-36. PMCID: PMC3796147

Fullerton CA, Kim ML, Thomas CP, Lyman DR, Montejano LB, Dougherty RH, Daniels AS, Ghose SS, Delphin-Rittmon ME. (2014). Medication-assisted treatment with methadone: Assessing the evidence. Psychiatric Services, 65(2):146-1557.

Garnick DW, Horgan CM, Acevedo A, Lee MT, Panas L, Ritter G, Dunigan R, Bidorini A, Campbell K, Haberlin K, Huber A, Lambert-Wacey D, Leeper T, Reynolds M, Wright D. (2014). Criminal justice outcomes after engagement in outpatient substance abuse treatment. Journal of Substance Abuse Treatment, 46:295-305. PMCID: PMC3947052

Harris AS, Chen C, Mohr BA, Adams RS, Williams TV, Larson MJ. (2014). Predictors of Army National Guard and reserve members’ use of Veterans Health Administration health care after demobilizing from OEF/OIF Deployment. Military Medicine, 179(10):1090-1098. PMCID: PMC4187225

Hodgkin D, Horgan CM, Quinn AE, Merrick EL, Stewart MT, Leslie LK. (2014). Management of newer medications for attention-deficit/hyperactivity disorder in commercial health plans. Clinical Therapeutics, 36(12):2034-2046. PMCID: PMC4282778

Hodgkin D, Piazza M, Crisante M, Gallo C, Fiestas F. (2014). The availability of psychotropic medications in Ministry of Health facilities in Peru. In Spanish. Revista Peruana de Medicina Experimental y Salud Pública, 31(4):660-668. Medical Care, 52(S12):S83-S90.

Kim ML, O’Brien PL, Thomas CP, Johnson J, Kreiner P. (2014). Prescription Behavior Surveillance System Project: Prescriber education and other initiatives literature report. Prepared for the U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Safe Use Initiative.

Larson MJ, Adams RS, Nikitin R, Garnick DW, Ritter G. (Eds.) (2014). Study on incidence of breast cancer among members of Armed Forces serving on active duty. Report To Congress: National Defense Authorization Act For Fiscal Year 2013 (HR-4310), Section 737. Submitted by the Office of the Assistant Secretary of Defense, Department of Health Affairs.

Larson MJ, Mohr BA, Adams RS, Wooten NR, Williams TV. (2014). Missed opportunity for alcohol problem prevention among Army active duty service members post-deployment. Am J Public Health, 104(8):1402-1412. PMCID: PMC4103229

Larson MJ, Mohr BA, Lorenz LS, Grayton C, Williams TV. (2014). General and specialist health care utilization in military children of Army service members who are deployed. In: Wadsworth, S.M., and Riggs, D. (Eds.), Military Deployment and its Consequences for Families. New York, NY: Springer.

Lee MT, Horgan CM, Garnick DW, Acevedo A, Panas L, Ritter G, Dunigan R, Babakhanlou-Chase H, Bidorini A, Campbell K, Haberlin K, Huber A, Lambert-Wacey D, Leeper T, Reynolds M. (2014). A performance measure for continuity of care after detoxification: Relationship with outcomes.  Journal of Substance Abuse Treatment, 47(2):130-139. PMCID: PMC4076006

Merrick EL, Hodgkin D, Horgan CM. (2014). Incentives to shape health behaviors: How can we make them more person-centered? Journal of Workplace Behavioral Health, 29(1):19-31.

O'Brien PL, Thomas CP, Hodgkin D, Levit KR, Mark TL. (2014). The diminished pipeline for medications to treat mental health and substance use disorders. Psychiatric Services, 65(12):1433-1438. PMCID: PMC4788407

Reif S, Braude L, Lyman R, Dougherty RH, Daniels AS, Ghose SS, Onaje Salim O, Delphin-Rittmon ME. (2014). Peer recovery support for individuals with substance use disorders: Assessing the evidence. Psychiatric Services, 65(7):853-861. DOI: 10.1176/appi.ps.201400047

Reif S, George P, Braude L, Dougherty RH, Daniels AS, Ghose SS, Delphin-Rittmon ME. (2014). Recovery housing: Assessing the evidence. Psychiatric Services, 65(3):295-300.

Reif S, George P, Braude L, Dougherty RH, Daniels AS, Ghose SS, Delphin-Rittmon ME. (2014). Residential treatment for individuals with substance use disorders: Assessing the evidence. Psychiatric Services, 65(3):301-312.

Shanahan C, Sorensen-Alawad A, Carney B, Persand I, Cruz A, Botticelli M, Pressman K, Adams WG, Brolin M, Alford DP. (2014). The implementation of an integrated information system for substance use screening in general medical settings. Applied Clinical Informatics, 5(4):878-894.

Thomas CP, Fullerton CA, Kim ML, Montejano L, Lyman DR, Dougherty RH, Daniels AS, Ghose SS, Delphin-Rittmon ME. (2014). Medication-assisted treatment with buprenorphine: Assessing the evidence. Psychiatric Services, 65(2):158-170.

Thomas CP, Kim ML, Nikitin RV, Kreiner P, Clark T, Carrow G. (2014). Prescriber response to unsolicited Prescription Drug Monitoring Program reports in Massachusetts. Pharmacoepidemiology and Drug Safety, 23(9):950-7. DOI: 10.1002/pds.3666

2013

Adams RS, Larson MJ, Corrigan JD, Ritter G, Williams TV. (2013). Traumatic brain injury among active duty military personnel and drinking-related negative consequences. Substance Use and Misuse, 48(10):821-836. PMCID: PMC3721380

Brolin M, Quinn AE, Sirkin JT, Horgan CM, Parks J. (2013). Financing of behavioral health services within federally qualified health centers.  Center for Financing Reform and Innovations (subcontract to Truven Health Analytics). Submitted to Substance Abuse and Mental Health Services Administration. Rockville, MD.

Corrigan JD, Adams RS, Larson MJ. (2013). When addiction co-occurs with traumatic brain injury. American Journal of Psychiatry, 170(4):351-354. PMCID: PMC3694416

Davis M, Brolin M. (2013). Focus group: Evaluation of substance abuse treatment program. In SAGE Research Methods Cases. London, United Kingdom: SAGE Publications, Ltd.  

Kolb B, Lorenz LS. (2013). Let’s See: Participatory visual methods in practice. In Fogel C, Quinlan E, and Quinlan A. (Eds.), Imaginative Inquiry: Innovative Approaches to Interdisciplinary Research. Palo Alto, CA: Academica Press.

Larson MJ, Adams RS, Mohr BA, Harris A, Merrick EL, Funk W, Hoffman K, Wooten NR, Jeffery DD, Williams TV. (2013). Rationale and methods of the Substance Use and Psychological Injury Combat Study (SUPIC): A longitudinal study of Army service members returning  from deployment in  FY2008- 2011. Substance Use and Misuse, 48(10):863-879. PMCID: PMC3793632

Larson MJ, Amodeo M, LoCastro JS, Muroff J, Smith L, Gerstenberger E. (2013). Randomized trial of web-based training to promote counselor use of cognitive behavioral therapy skills in client sessions. Substance Abuse, 34(2):179-187. PMCID: PMC4073477

Larson MJ, Lorenz LS. (2013). Upstream opportunities for reducing the harm of alcohol and drug use. Waltham, MA: Institute for Behavioral Health, Schneider Institutes for Health Policy, Heller School for Social Policy and Management, Brandeis University.

Larson MJ, Ritter GA, Adams RS. (2013). Suicides among military personnel. Journal of the American Medical Association, 310(23):2565. PMCID: PMC4132876

Lorenz LS. (2013). Photovoice in practice: Ensuring safety and encouraging action. In Lichtman M. (Ed.), Qualitative Research for the Social Sciences. Thousand Oaks, CA: Sage Publications.

Ryan M, Merrick EL, Hodgkin D, Horgan CM, Garnick DW, Panas L, Ritter G, Blow FC, Saitz R. (2013). Drinking patterns of older adults with chronic medical conditions. Journal of General Internal Medicine, 28(10):1326-32. PMCID: PMC3785666

Thomas CP, Garnick DW, Horgan C, Miller K, Harris AG, Rosen MM. (2013). Establishing the feasibility of measuring performance in use of addiction pharmacotherapy. Journal of Substance Abuse Treatment, 45(1): 11-18. PMCID: PMC3954716 

Thomas CP, Kim M, Kelleher SJ, Nikitin RV, Kreiner PW, McDonald A, Carrow GM. (2013). Early experience with electronic prescribing of controlled substances in a community Setting. Journal of American Medical Informatics Association, 20(e1):e44-51. PMCID: PMC3715357

Wooten NR, Mohr BA, Lundgren LM, Adams RS, Merrick EL, Williams TV, Larson MJ. (2013). Gender differences in substance use treatment utilization in the year prior to deployment in Army service members. Journal of Substance Abuse Treatment, 45(3): 257-265. PMCID: PMC3755744

2012

Acevedo A, Garnick DW, Lee MT, Horgan CM, Ritter G, Panas L, Davis S, Leeper T, Moore R, Reynolds M. (2012). Racial and ethnic differences in substance abuse treatment initiation and engagement in a publicly-funded substance abuse treatment system. Journal of Ethnicity in Substance Abuse, 11(1):1-21.

Adams RS, Corrigan JD, Larson MJ. (2012). Alcohol use after combat-acquired traumatic brain injury: What we know and don't know. J Soc Work Pract Addict, 12(1):28-51. PMCID: PMC3319372. 

Adams RS, Larson MJ, Corrigan JD, Horgan CM, Williams TV. (2012). Frequent binge drinking after combat-acquired traumatic brain injury among active duty military personnel with a past year combat deployment. The Journal of Head Trauma Rehabilitation, 27(5):349-360. PMCID: PMC3633079.

Clark T, Eadie J, Kreiner P, Strickler G. (2012). Prescription Drug Monitoring Programs: An assessment of the evidence for best practices. Prescription Drug Monitoring Program Center of Excellence. Prepared for the Pew Charitable Trusts.

Garnick DW, Horgan CM, Acevedo A, McCorry F, Weisner C. (2012). Performance measures for substance use disorders - what research is needed? Addiction Science & Clinical Practice, 7(1):18.  PMCID: PMC3564737

Garnick DW, Lee MT, O’Brien ML, Panas MS, Ritter GA, Acevedo A, Garner BR, Frank RR, Godley MD. (2012). The Washington Circle engagement performance measures’ association with adolescent treatment outcomes. Drug and Alcohol Dependence, 124:250-258.

Hodgkin D, Merrick EL, Hiatt D. (2012). The relationship of antidepressant prescribing concentration to treatment duration and cost. Journal of Mental Health Policy and Economics, 15(1):3-11.

Kreiner P. (2012). Prescription Drug Monitoring Program Center of Excellence at Brandeis. Notes from the field.

Larson MJ, Mohr BA, Adams RS, Ritter G, Perloff J, Williams TV, Jeffrey DD, Tompkins C. (2012). Association of military deployment of a parent or spouse and changes in dependent use of health care services. Medical Care, 50(9):821-828. 

Larson MJ, Wooten N, Adams RS, Merrick EL. (2012). Military combat deployments and substance use: Review and future directions. Journal of Social Work Practice in the Addictions, 12(1):6-27. PMCID: PMC3321386

Lee MT, Garnick DW, O'Brien PL, Panas L, Ritter GA, Acevedo A, Garner BR, Funk RR, Godley MD. (2012). Adolescent treatment initiation and engagement in an evidence-based practice initiative. Journal of Substance Abuse Treatment, 42(4):346-355. PMCID: PMC3345887

Lorenz LS. (2012). A way into empathy: A “Case” of photo-elicitation in illness research. In Hughes J. (Ed.), SAGE Visual Methods (Volume 4). London: SAGE Publications. 

McCann B, Hiatt D, Azzone V, Merrick E. (2012). EAP purchasing preferences. Journal of Employee Assistance, 42(3):18-20. 

McLellan DL, Hodgkin D, Fagan P, Reif S, Horgan CM. (2012). Unintended consequences of cigarette price changes for alcohol drinking behaviors across age groups: Evidence from pooled cross sections. Substance Abuse Treatment, Prevention, and Policy, 7(28). PMCID: PMC3441210

Merrick EL, Reif S, Hiatt D, Hodgkin D, Horgan CM, Ritter G. (2012). Substance abuse treatment client experience in an employed population: Results of a client survey. Substance Abuse Treatment Prevention and Policy, 7(4):17. PMCID: PMC3269994

Reif S, Torres M, Horgan CM, Merrick EL. (2012). Characteristics pf practitioners in a private managed behavioral health plan. BMC Health Services Research, 12:283. PMCID: PMC3577445

Ruzek J, Rosen R, Marceau L, Larson MJ, Garvert D, Smith L, Stoddard A. (2012). Online self-administered training for post-traumatic  stress disorder treatment providers: Design and methods for a randomized, prospective intervention study. Implementation Science, 7(43). PMCID: PMC3405469

Schmidt LA, Tam TW, Larson MJ. (2012). Sources of biased inference in alcohol and drug services research: An instrumental variable approach. Journal of Studies on Alcohol and Drugs, 73(1):144-153. PMCID: PMC3237705

Strickler GK, Reif S, Horgan C, Acevedo A. (2012). The relationship between substance abuse performance measures and mutual help group participation after treatment. Alcoholism Treatment Quarterly, 30(2):190-210.  PMCID: PMC3412672

Strickler GK, Reif S, Merrick EL, Horgan CM, Hiatt, D. (2012). Substance abuse treatment preferences in an employed population. Journal of Workplace  Behavioral Health, 27(2):17-125. 

2011

Daley M, Shepard DS, Tompkins CP, Dunigan R, Reif S, Perloff J, Siembab L, Horgan CM. (2011). Randomized trial of enhanced profiling in substance abuse treatment. Administration and Policy in Mental Health and Mental Health Services Research, 38(2):96-104. PMCID: PMC3040276

Garnick DW, Lee MT, Horgan CM, Acevedo A, Botticelli M, Clark S, Davis S, Gallati R, Haberlin K, Hanchett A, Lambert–Wacey D, Leeper T, Siemianowski J, Tikoo M. (2011). Lessons from five states: Public sector use of Washington Circle performance measures. Journal of  Substance Abuse Treatment, 40(3):241–254.  PMCID: PMC3085924

Hiatt D, Horgan CM, Greenfield S, McCann B. (2011). Integrated EAP/managed behavioral health plan utilization by persons with substance use disorders. Journal of Substance Abuse Treatment, 40(3):299-306. PMCID: PMC3056945

Hodgkin D, Volpe-Vartanian J, Merrick EL, Horgan CM, Nierenberg AA, Frank RG. (2011). Customization in prescribing for bipolar disorder. Health Economics, 21(6):653-68. PMCID: PMC3164906

Lorenz LS. (2011). A way into empathy: A ‘case’ of photo-elicitation research. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 15(3):259-275.

Lorenz LS, Chilingerian J. (2011). Using visual and narrative methods to achieve fair process in clinical care. Journal of Visualized Experiments, 48:2342.  PMCID: PMC3197387 

Merrick EL, Hodgkin D, Garnick DW, Horgan, CM, Panas L, Ryan M, Blow F, Saitz R. (2011). Older adults’ inpatient and emergency department utilization for ambulatory-care-sensitive conditions: Relationship with alcohol consumption. Journal of Aging and Health, 23(1):86-111. PMCID: PMC3021178

Merrick EL, Hodgkin D, Hiatt D, Horgan CM, Greenfield SF, McCann B. (2011). Integrated employee assistance program/managed behavioral health plan utilization by persons with substance use disorders. Journal of Substance Abuse Treatment, 40(3):299-306. PMCID: PMC3056945

Merrick EL, Hodgkin D, Hiatt D, Horgan CM, McCann B. (2011). EAP service use in a managed behavioral healthcare organization: From the employee perspective. Journal of Workplace Behavioral Health, 26(2):85-96. PMCID: PMC3182492

Merrick EL, Hodgkin D, Horgan CM, Panas L, Soumerai S, Ritter G. (2011). Is customization in antidepressant prescribing associated with acute-phase treatment adherence? Journal of Pharmaceutical Health Services Research, 3(1):11-16. PMCID: PMC3374329

Reif S, Horgan CM, Garnick DW, McLellan DL. (2011). Systems-level smoking cessation activities by private health plans. Preventing Chronic Disease, 8(1). PMCID: PMC3220629

Reif S, Larson MJ, Cheng D, Allensworth-Davies D, Samet J, Saitz R. (2011). Chronic disease and recent addiction treatment utilization among alcohol and drug dependent adults. Substance Abuse Treatment, Prevention, and Policy, 6:28.  PMCID: PMC3220629

Reif S, Ritter GA, Horgan CM. (2011). Treatment services: Triangulation of methods when there is no gold standard. Substance Use & Misuse, 46(5):620-632.

Thomas CP, Garnick DW, Horgan CM, McCorry F, Gmyrek A, Chalk M, et al. (2011). Advancing performance measures for use of medications in substance abuse treatment. J Subst Abuse Treat, 40(1):35-43. PMCID: PMC2997925

Tschampl C, Bernardo J, Garvey T, Garnick DW. (2011). The need for performance measures on testing for latent tuberculosis infection in primary care. The Joint Commission Journal on Quality and Patient Safety, 37(7):309-316.

Wittenberg E. (2011). The effect of time of onset on community preferences for health states: an exploratory study.  Health and Quality of Life Outcomes, 9(6). PMCID: PMC3031192

Wittenberg E, Prosser L. (2011). Ordering errors, objections and invariance in utility survey responses: a framework for understanding who, why and what to do. Applied Health Economics and Health Policy, 9(4):225-41

2010

Amodeo M, Storti SA, Larson MJ. (2010). Moving empirically supported practices to addiction treatment programs: recruiting supervisors to help in technology transfer. Subst Use Misuse, 45(6):968-82. PMCID: PMC3711078

Daley M, Shepard DS, Reif S, Dunigan R, Tompkins CP, Perloff J, Siembab L, Horgan CM. (2010). Evaluation of provider profiling in the public sector. Alcoholism Treatment Quarterly, 28(4):376-390.

Garner BR, Godley MD, Funk RR, Lee MT, Garnick DW. (2010). The Washington Circle continuity of care performance measure: predictive validity with adolescents discharged from residential treatment. J Subst Abuse Treat, 38(1):3-11. PMCID: PMC2789887.

Hodgkin D, Karpman HE. (2010). Economic crises and public spending on mental health care. International Journal of Mental Health, 39(2):91-106.

Hodgkin D, Merrick EL, Hiatt D, Horgan CM, McGuire TG. (2010). The effect of Employee Assistance Plan benefits on the use of outpatient behavioral health care. Journal of Mental Health Policy and Economics; 13(4):167-174. PMCID: PMC3081606 

Katz N, Panas L, Kim M, Audet AD, Bilansky A, Eadie J, et al. (2010). Usefulness of prescription monitoring programs for surveillance - analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf, 19(2):115-23.

Larson MJ, McGraw S. (2010). Physical illness and medical needs of women with mental disorders (Chapter 5, pp 81-105). In Becker M and Levin B. (Eds.), A Public Health Perspective of Women's Mental Health. New York, NJ: Springer, 2010. 

Lorenz LS. (2010). Brain injury survivors: Narratives of rehabilitation and healing. Boulder, CO: Lynne Rienner Publishers, Inc; 2010.

Lorenz LS. (2010). Discovering a new identity after brain injury. Sociology of Health and Illness, 32(6):862-879.

Lorenz LS. (2010). Visual metaphors of living with brain injury: Exploring and communicating lived experience with an invisible injury. Visual Studies, 25(3):210-223.

McCann B, Azzone V, Merrick EL, Hiatt D, Hodgkin D, Horgan CM. (2010). Employer choices in EAP design and worksite services. Journal of Workplace Behavioral Health, 25(2):89-106. PMCID: PMC3388531

McGraw SA, Larson MJ, Foster SE, Kresky-Wolff M, Botelho EM, Elstad EA, et al. (2010). Adopting best practices: Lessons learned in the Collaborative Initiative to Help End Chronic Homelessness (CICH). J Behav Health Serv Res, 37(2):197-212.

Merrick EL, Hodgkin D, Garnick DW, Horgan CM, Panas L, Ryan M, Blow FC, Saitz R. (2010). Older adults' inpatient and emergency department utilization for ambulatory-care-sensitive conditions: Relationship with alcohol consumption. Journal of Aging and Health, 23(1):86-111. PMCID: PMC3021178

Merrick EL, Hodgkin D, Hiatt D, Horgan CM, Azzone V, McCann B, et al. (2010). Patterns of service use in two types of managed behavioral health care plans. Psychiatric Services, 61(1):86-9. PMCID: PMC2801078.

Merrick EL, Hodgkin D, Hiatt D, Horgan CM, Greenfield SF, McCann B. (2010). Integrated employee assistance program/managed behavioral health plan utilization by persons with substance use disorders. Journal of Substance Abuse Treatment, 40(3):299-306. PMCID: PMC3056945

Merrick EL, Horgan CM. (2010). Invited book review of Mental Health Services: A Public Health Perspective (Third Edition), edited by B. L. Levin, K.D. Hennessey, J. Petrila. New York: Oxford. Journal of Behavioral Health Services and Research, Epub ahead of print December 24, 2010.

Merrick EL, Perloff J, Tompkins C. (2010). Emergency department utilization among Medicare beneficiaries with serious mental disorders. Psychiatric Services, 61(6):628-631.

Merrick EL, Reif S. (2010). Services in an era of managed care. In Becker MA, Levin BL, editors. A Public Health Perspective of Women's Mental Health. New York: Springer Publications; pp. 201-28.

Ozanne EM, Wittenberg E, Garber JE, Weeks JC. (2010). Breast cancer prevention: patient decision making and risk communication in the high risk setting. Breast J, 16(1):38-47.

Peller AJ, Najavits LM, Nelson SE, LaBrie RA, Shaffer HJ. (2010). PTSD among a treatment sample of repeat DUI offenders. Journal of Traumatic Stress, 23(4):468-473. 

Reif S, Horgan CM, Torres M, Merrick E. (2010). Economic grand rounds: Types of practitioners and outpatient visits in a private managed behavioral health plan. Psychiatr Serv, 61(11):1066-8. PMCID: PMC3848051

Wallack SS, Thomas CP, Martin TC, Chilingerian J, Reif S. (2010). Substance abuse treatment organizations as mediators of social policy: slowing the adoption of a congressionally approved medication. J Behav Health Serv Res, 37(1):64-78.

2009

Azzone V, McCann B, Merrick EL, Hiatt D, Hodgkin D, Horgan CM. (2009). Workplace stress, organizational factors and EAP utilization. Journal of Workplace Behavioral Health, 24:344-56. PMCID: PMC3778910

Browne CA, Larson MJ, Miller K, Cowell AJ. (2009). Datapoints: racial and ethnic patterns in claim-identified mental disorders among disabled medicare beneficiaries. Psychiatr Serv, 60(12):1586. PMCID: PMC3085924

Garnick DW, Lee MT, Horgan CM, Acevedo A. (2009). Washington Circle Public Sector Workgroup. Adapting Washington Circle performance measures for public sector substance abuse treatment systems. J Subst Abuse Treat, 36(3):265-77. PMCID: PMC2653590.

Hodgkin D, Horgan CM, Garnick DW, Merrick EL. (2009). Benefit limits for behavioral health care in private health plans. Adm Policy Ment Health, 36(1):15-23. PMCID: PMC2644559.

Horgan CM, Garnick DW, Merrick EL, Hodgkin D. (2009). Changes in how health plans provide behavioral health services. J Behav Health Serv Res; 36(1):11-24. PMCID: PMC2982768

Lorenz LS, Kolb B. (2009). Involving the public through participatory visual research methods. Health Expectations, 12:262-74.

Merrick EL, Hodgkin D, Horgan CM, Hiatt D, McCann B, Azzone V, et al. (2009). Integrated employee assistance program/managed behavioral health care benefits: relationship with access and client characteristics. Adm Policy Ment Health, 36(6):416-23. PMCID: 2794127.

Merrick EL, Horgan CM, Garnick DW, Reif S, Stewart MT. (2009). Accessing specialty behavioral health treatment in private health plans. J Behav Health Serv Res, 36(4):420-35.

Sher DJ, Wittenberg E, Suh WW, Taghian AG, Punglia RS. (2009). Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys, 74(2):440-6. PMCID: 2695677.

Wright DR, Wittenberg E, Swan JS, Miksad RA, Prosser LA. (2009). Methods for measuring temporary health states for cost-utility analyses. Pharmacoeconomics, 27(9):713-23.